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ABSTRACT

The purpose of this study was to investigate the results of a practical
application of a low frequency electrical stimulation (LFES) program of 8 pps to
individuals with multiple sclerosis. Previous research has shown that such a
program induces a conversion of fast twitch muscle properties to those of slow
twitch. Electrical stimulation was applied for 3 hours per day, 6 days a week, for
6 weeks, to the quadriceps femoris muscle of nine subjects with multiple sclerosis.
Pre and post measurements of average peak torque, mean force, and fatigue slope
were taken as indices of the muscle's strength and endurance. Contralateral
quadriceps muscles were used as control. A two-tailed analysis of variance with
two within subject factors was used to analyze the data. Statistical significance
(p<. 05) was not demonstrated for the experimental leg as contrasted to the
control leg for any of these variables; however, a strong trend for increasing peak
torque (p<. 1 1) and mean force (p<. l O) was exhibited for the stimulated
quadriceps muscle above that of the unstimulated control muscle. In view of the
clinical nature of the research design, further investigation of these trends should
be considered. Fatigability decreased in both the experimental and control legs
suggesting a possible cross-training effect. Subjective responses were favorable
and functional improvements were reported by all subjects. The study does
establish LFES as a safe and comfortable option for inducing endurance exercise
training on a muscle weakened due to MS. However, more research is needed to
ill

determine the extent of its usefulness and to ascertain the optimum protocol
parameters.
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CHAPTER 1

INTRODUCTION

The clinical use of neuromuscular electrical stimulation to increase strength
and improve function in both normal and patient populations has been employed
since the eighteenth century. 1 In this procedure, transcutaneous electrical
impulses stimulate the peripheral nerves to produce skeletal muscle contractions. 2
The plasticity of muscle fibers and the mutability of their contractile
characteristics became the focus of investigations after Buller et al. 3 demonstrated
in 1960 that muscle properties can be altered in response to neural stimuli.
Electrical stimulation, due to its ability to elicit muscular contractions via neural
excitation, was quickly employed as a methodological tool in research exploring
the changes induced in muscle fibers in response to the various stimulation
frequencies and patterns of activity delivered to them.
Research of the biochemical and physiological effects induced in the muscle by
electrical stimulation in animal models has been ongoing for several decades. 4•13
These studies mainly involved stimulation to the nerve by direct contact. Studies
with human subjects have documented similar changes primarily utilizing
. 14-24
. lat1on.
c.
the stmm
transcutaneous e1ectrodes .1or

1

The results of these studies have demonstrated the capability of skeletal
muscle properties to change in response to different electrical stimulation
protocols. The majority of research has shown that low frequency electrical
stimulation (LFES ), generally in the range of 8-10 Hz, can modify muscle
properties such that fast twitch muscles express the characteristics of slow twitch
muscles. These changes have been delineated in terms of muscle contractile
characteristics, muscle fatigability, histological fiber types, metabolic enzyme
activity, and myofibrillar proteins. Decreases in the muscle's fatigability have
been noted

1
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and, if the muscle is weakened by a disease process, increases

in the muscle's strength may occur as well. 17'

25

Changes are not permanent and a

reversion to previous muscle properties occurs shortly after cessation of electrical
stimulation. Low frequency electrical stimulation, when used to simulate the
frequency and pattern of activity of motor neurons with slow conduction
velocities, is thought to alter the phenotypic expression of muscle fibers as
opposed to inducing new fiber development, or destroying pre-existing fibers. 8-10
As a result of these findings, the clinical application of electrical stimulation
has taken on new importance by expanding its possible therapeutic value to a
broader patient population. Previous clinical research and application had
primarily utilized a higher frequency electrical stimulation directed towards
increasing the strength of musculosketally injured patients, 26 or functional ability
of spinal cord injury patients.

7

2

Most commonly for these purposes, 50 bursts per
2

second are delivered via a 2500 Hz carrier frequency. Low frequency electrical
2

stimulation, usually delivered below 3 0 Hz, offers an opportunity to increase the
endurance capacity of a muscle and, possibly, the strength of a muscle at a much
more comfortable delivery frequency. The ability of a LFES program to increase
muscle strength and endurance has been employed by a wide range of medical
disciplines, from spinal cord rehabilitation 2
education. 29'

30

3

'

28

to post-surgical muscle re

More recent research has included animal subjects 25 and human

subjects1 7' 31 with neuromuscular diseases in hopes of discovering a method of
increasing strength and endurance of muscles altered by disease.
Scott et al. 17 utilized a low frequency electrical stimulation protocol and a
higher (40 Hz) electrical stimulation m�scle testing procedure on the quadriceps
muscle of children with muscular dystrophy. These researchers reported increases
in the mean maximal voluntary contraction for the stimulated muscles. The low
frequency electrical stimulation of 8 Hz, 3 hr/day, was tolerated well by the
children and did not impede regular activity. Peckham et al. 2 8 reported increases
in force and decreases in fatigability in muscles of individuals with central nervous
system (CNS) lesions after receiving 10 Hz stimulation. Determining other
patient populations or disease processes that may benefit from a LFES program
merits further investigation.
Multiple sclerosis, an adult onset neurological disease causing demyelinization
in the white matter of the brain and spinal cord, 32' 3 is a disease which may benefit
3

from a LFES protocol. The clinical picture is variable and distinctive for each
individual, reflecting the affected areas of the central nervous system, but the
3

overall process is of progressive decline in functional strength and ability. 34
Evaluation of muscle characteristics in individuals with multiple sclerosis has
suggested a transformation of fatigue resistant muscle fibers to fatigable ones,
based on decreases in muscle endurance as determined by electrical stimulation
testing techniques. 21 Other researchers have proposed that a conversion to Type
II (fast twitch) muscle fibers occurs in any condition which decreases normal
mechanical stretch or stimulus, 35 as could be the case in individuals weakened by
disease.
lsokinetic dynamometry has been used to document decreases in muscular
strength and endurance of the quadriceps and hamstring muscles in individuals
with multiple sclerosis. 36-38 A resistive exercise program has been shown to
benefit multiple sclerosis individuals who still have sufficient strength and ability
to participate in such a program. 39 These improvements in muscle function
suggest the possibility that muscles in individuals with multiple sclerosis are still
amenable to change in response to a volitional imposed training stimulus.
Unfortunately, few options are available for the individual too weak for resistive
training. This weaker group of multiple sclerosis individuals may stand to benefit
most from a LFES program which can passively provide a training stimulus.
LFES may maximize the weakened muscle's capability and possibly restore it to a
level where volitional exercise can be initiated.
This study seeks to incorporate the proven physiological changes in muscle
fibers due to LFES into a viable clinical protocol and consider its utility in a
4

patient population. More specifically, the purpose of this study is to evaluate the
effects of a LFES program to the quadriceps muscle of individuals with multiple
sclerosis by assessing any changes in the muscle's strength and endurance.

Basic Terminology

Several terms used in the discussion of electrical stimulation research are often
vague in their meaning. The following terms and their definitions are presented
to clarify the intended definitions for this discussion. The Clinical
Electrophysiology section of the American Physical Therapy Association is
working to standardize electrotherapeutic terminology in its field. The definitions
below are taken from the report published in 1990 by the Electrotherapy
Standards Committee of this section of the American Physical Therapy
Association. 40 In some cases, discrepancies which may appear in the literature are
noted.

Alternating Current: An uninterrupted bi-directional flow of charged particles

which can be either symmetrical or asymmetrical. Most frequently termed AC
current.
Pulsed Current: Can be either a bi-directional or unidirectional flow of particles

that periodically ceases for a finite period of time. The pulse is an isolated
electrical event. This type of current is often erroneously called "interrupted AC",
but this is not considered the preferred terminology.
5

Waveform: The visual representation of pulsed current on a current/time plot.
Phase: Current flow in one direction for a finite period of time. It may be either
monophasic, deviating from the zero current baseline in one direction only, or
biphasic, deviating from the baseline first in one direction, then in the opposite
direction. Biphasic waveforms may be either symmetrical or asymmetrical.
Asymmetrical Biphasic: A waveform in which the deviation in one direction of
the baseline is not equal to the deviation in the opposite direction.
Symmetrical Biphasic: A waveform in which the deviations on either side of the
zero current baseline are equal.
Phase Duration: The time elapsed from the beginning to the end of one phase of
a pulse or cycle. Usually expressed in microseconds or milliseconds. In a biphasic
waveform, the deviation in each direction has a specific phase duration. The
interphase interval is the period of electrical silence between each component
phase of a pulse.
Rise Time: The time required for the beginning of the phase to go from the zero
baseline to its peak amplitude, often referred to as ramp up time.
On Time/Off Time: On time is the time (usually in seconds) in which a train of
pulses is delivered. The off time (in seconds) is the time between the trains of
pulses. This may also be expressed as a ratio, such as 1 :2 for an on time often
seconds and an off time of twenty seconds. This is often mislabeled as the duty
cycle.

6

Frequency: For pulsed current, frequency is the number of pulses per second
delivered and is expressed as such in ''pps". For alternating currents, frequency is
the number of cycles per second and is expressed in hertz (Hz). The terms of
low, medium, and high frequency are not encouraged by the Clinical
Electrophysiology section of APTA; however, the term "low frequency" has been
used extensively in the literature since the. onset of research in this field such that
exclusion of this term in this paper would be most difficult, if not impossible. For
clarification, a low frequency electrical stimulation (LFES) program in the
literature is one in which the frequency ofstimulation delivered is usually between
8-10 Hz or pp s, and on occasion includes research protocols using frequencies of
15-30 Hz or pps.

7

CHAPTER2

LITERATURE REVIEW

The progression ofresearch on electrical stimulation and its effects on muscle
properties can be separated according to whether animal or human models were
used in the research design. In studies using animal models, the research can be
considered along two lines: those studies focusing on determining what electrical
stimulation parameters induce changes in muscle properties, and those that focus
on determining more specifically the nature ofthese changes induced in the
muscle by the electrical stimulation. Although these themes ofresearch overlap in
many studies, separation along these lines allows for a clearer review ofthe
literature. The research using human models seeks to apply these findings in a
practical low frequency electrical stimulation protocol in healthy and clinical
populations with the hope ofdiscovering a method ofimproving muscle function
for clinical populations. In this literature review, research on both animal and
human models will be covered. Subsequent to this, justification for further
clinical investigations will also be presented, and multiple sclerosis will be
considered as a possible disease that may benefit from a LFES program.

8

Animal Models

Research Determining the Appropriate Electrical Stimulation Parameters: In
1960, Buller et al. 3 published the results of their cross-innervation experiments on
the hindlimb of cats. This study reported that slow twitch muscles, when cross
innervated with motor neurons from a fast twitch muscle, transformed in such a
manner that the slow twitch muscles expressed the contractile properties of the
fast twitch muscle. The predominantly slow twitch soleus muscle was noted to
have a decrease in contraction time and in half-relaxation time after cross
innervation from a predominantly fast twitch flexor digitorum longus muscle. The
reverse was also found to be true. Fast twitch muscles, cross-innervated with
motor neurons from the slow twitch muscles, expressed the muscle contractile
characteristics associated with slow muscles, demonstrating a slowing in
contraction time and half-relaxation time. These findings led the authors to
generally conclude that the speed of a muscle is determined by the motor neuron
innervating it, and that this muscle property is mutable. The neural influence
responsible for this was considered to be mediated by a substance passing down
the axon and going into the muscle fibers. They further determined that this neural
influence was exhibited in adult cats as well as in developing young kittens,
indicating that this process continued throughout life. The concept of a
''neurotrophic influence" in this hallmark study spawned research investigating
other plausible mechanisms by which the motor neuron may determine or alter the
characteristics of muscle. Electrical stimulation became a widely used
9

methodological tool in these types of studies due to its ability to emulate different
motor neuron transmission traits.
As an alternative concept to the transmission of a neural substance, the
results of two studies by Vrbova

4 41

'

suggested that impulse activity in the motor

neuron may be responsible for changes in muscle properties. Vrbova first
documented the typical electromyographic (EMG) activity of slow twitch and fast
twitch muscles by performing tenotomies in rabbits. 4 Slow twitch soleus muscles
1

were noted to exhibit a continuous EMG activity, in contrast to fast twitch
muscles which demonstrated occasional bursts of activity on an otherwise silent
background. Subsequent to this study, Vrbova analyzed the effects of motor
neuron activity on muscle speed characteristics. 4 In a series of experiments,
Vrbova created conditions of decreased impulse activity on the soleus muscle by
performing tenotomies of all the tendons around the ankle joint of rabbits and
cats. This resulted in the slow soleus muscle exhibiting shorter contraction and
relaxation times, similar to that of fast twitch muscles. The researchers attributed
these changes to the decreased impulse activity in the motor neuron. The already
fast twitch plantaris muscle did not exhibit these changes. Conversely, excessive
use of a muscle resulted in slower contraction and relaxation times, whether it was
a slow twitch muscle like the soleus, or a fast twitch muscle such as the plantaris,
extensor digitorum longus, or tibialis anterior. Vrbova attributed the slowing of
contractile characteristics of both muscle types to the increased impulse
transmission from the overload condition. Although Vrbova concluded impulse
10

activity of the motor neuron was important in determining the mechanical
responses of muscles, no distinction was made as to whether these changes were
due to the frequency, or the duration of the motor neuron discharge.
Salmons and Vrbova5 expanded upon the findings of impulse activity affecting
contractile characteristics by testing different frequencies of electrical stimulation
to the tenotomized soleus muscle of rabbits. Previous studies had indicated that
motor neurons to slow twitch muscles discharge at a frequency of l O to 20
impulses/second and those to fast twitch muscles discharge at 30 to 60
impulses/second. 42 Salmons and Vrbova postulated that subjecting muscles to
different frequencies of activity should alter the muscle's contractile
characteristics. They found that the tenotomized slow twitch soleus muscle could
be prevented from acquiring the faster contraction and relaxation times associated
with ·tenotomy if long term electrical stimulation using a frequency of 5 or I 0/sec
was done after tenotomy. However, stimulation at a higher frequency of 20 or
40/sec did not prevent the acquisition of fast twitch muscle characteristics after
tenotomy. Conversely, continuous stimulation at l 0/sec for up to 6 weeks to the
fast twitch tibialis anterior and extensor digitorum longus muscles of the rabbit
resulted in these muscles exhibiting slower contractile characteristics. The study
emphasized the importance of the frequency of the impulse activity in determining
muscle characteristics. A further point of interest is how the researchers related
the frequency and impulse activity imposed upon a muscle to the function of that
muscle, as in locomotion. Muscles such as the soleus which are involved in
11

maintaining balance and posture, should be expected to exhibit slower contraction
and relaxation times as compared to muscles more typically involved in rapid
reflexive movements such as the flexor hallicus longus. In this way, muscles are
able to specifically adapt to their particular functional role.
The frequency and duration of electrical impulses were not the only factors
being investigated for possible influences on the contractile characteristics of
muscles. Lomo et al. 6 studied the effect of the pattern of activity imposed upon
the muscle by electrical stimulation. Neurotrophic factors were eliminated by
resecting part of the sciatic nerve in rats, allowing for experimentation on
denervated slow twitch soleus muscles. Two groups of rats received stimulation
to their soleus muscle. The mean frequency of the stimulation was 2 Hz in both
groups, although different delivery methods to each group resulted in two
different patterns of muscle activity. One group received I00 Hz stimulation for
. 5 seconds repeated every 25 seconds to simulate the briefer, phasic activity of
fast twitch muscles. The other group received IO Hz stimulation lasting I0
seconds and repeated_ every 50 seconds in an effort to mimic the more tonic
activity of slow twitch muscles. Stimulation was performed in vivo for 3 to 6
weeks. The different training protocols resulted in the two groups exhibiting
different muscle contractile characteristics. The soleus muscles stimulated with
the phasic pattern of activity demonstrated contractile characteristics more typical
of fast twitch muscles than normal slow twitch soleus muscles. The muscles
stimulated with 10 Hz, the more tonic activity pattern, had contractile properties
12

similar to normal soleus muscles. The observed changes in muscle contractile
characteristics were supported by muscle biopsies. This finding is complementary
to Salmons and Vrbova's5 determination that slow to fast changes in contractile
characteristics of a tenotomized soleus muscle could be prevented with long term
low frequency electrical stimulation. This change was not prevented with the
phasic pattern of stimulation.
Lomo and associates6 also noted that the conversion to fast twitch muscle
properties was not complete in this study. The 100 Hz stimulated muscles did not
exhibit a characteristic "sag" in tension seen in Type II muscles during the initial
response to tetanic stimulation. These stimulated muscles also continued to be
more fatigue resistant in tetanic stimulation than normal fast twitch muscles. This
led the investigators to suggest that endurance and contractile speeds of muscle
may be controlled separately, with resistance to fatigue more specifically related
to the overall pattern of activity in the muscle. A similar finding had been noted by
Buller et al. 3
Hudlicka et al. 43 gave further support for the importance of the overall amount
of activity, as opposed to the stimulation frequency, in inducing changes in muscle
contractile characteristics. These researchers included resistance to fatigue during
isometric twitch as a contractile property of the muscle. The fast twitch muscles
of two groups of rabbits were stimulated and compared to a control group. The
pattern of activity was the same for both experimental groups with continuous
electrical stimulation being delivered 8 hours a day for 28 days; however, one
13

group received 10 Hz stimulation while the other group received 40 Hz
stimulation. Muscle contraction time and resistance to fatigue during isometric
twitch contraction were increased in both experimental groups, and indicated a
slowing of the muscles stimulated regardless of the frequency. The 10 Hz
stimulation was reported to yield greater and more consistent increases on these
two muscle properties. Resistance to fatigue was quantified by delivering 4 Hz
electrical stimulation continuously for IO minutes; the muscle tension produced at
the end of the stimulation was expressed as a percent of the maximum tension
developed during this period. The researchers also noted that peak tension
decreased during the first few days of electrical stimulation in both groups as
compared to the control group, but this difference was not apparent after 14 days
of stimulation. By the end of 28 days, the muscles stimulated at 40 Hz developed
more tension than either the control group or the 10 Hz group. Decreases in fiber
diameter were seen in conjunction with a change from Type II to Type I fibers in
the 40 Hz stimulated group. Results were not reported for the 10 Hz stimulated
group.
Sreter et al. 12 expanded upon the findings of Hudlicka et al. by stimulating the
same fast twitch muscles in rabbits at 60 Hz for 2. 5 seconds every 10 seconds, to
emulate the higher frequency phasic pattern of stimulation. This was considered
similar to that naturally received by fast twitch muscles; however, the stimulation
was delivered continuously for 5 weeks. This resulted in the same transformation
of fast to slow twitch muscle properties, as determined by histochemistry, myosin
14

ATPase activity, and myosin light chains, that lower frequencies of stimulation
had induced. The changes exhibited a gradual evolutional process and emphasized
the total amount of muscle activity induced by stimulation as being influential in
transforming muscle fiber properties. Eerbeek et al. 44 confirmed similar
transformations from fast to slow twitch muscle characteristics regardless of
whether the stimulation was at a low or high frequency, as long as the stimulation
activity was greater than 50 percent of the total activity time.
As a result of the above studies, the ability to transform a muscle from the
expression of fast twitch muscle characteristics to that of slow twitch muscle
characteristics became a well established concept. The idea of the pattern, or
total amount, of activity as being influential in inducing these changes, instead of
just the frequency of stimulation delivered, became apparent. While these
determinations were being made, other investigators were considering the nature
of the changes in the muscle fibers induced by the electrical stimulation.

Research Determining the Nature of Changes in Muscle Properties: One of the
earlier investigations in this area was done by Brown et al 45 These researchers
sought to determine the mechanisms responsible for the increased resistance to
fatigue as a result of LFES. Rabbit tibialis anterior and extensor digitorum longus
muscles, typically fast twitch muscles, were stimulated at a frequency of I O Hz, 8
hours a day, for 2 to 28 days. The researchers concluded that the chronic
stimulation caused an increase in capillary number allowing for more blood flow
15

into the muscle. Since no increase in glycolytic enzymes were noted, but an
increased activity of fatty acid activating enzyme did occur, the investigators
concluded that this may be suggestive of the muscles using more fats as a source
of energy.
With improvements in technology, researchers were able to discern in greater
detail the changes that occurred in contractile characteristics, histological profiles,
and immunocytochem.ical profiles, as a result of electrical stimulation programs;
this lent more support for the plasticity of muscle properties. The preponderance
of the studies focused on the conversion of fast twitch muscles to slow twitch
muscles using a low stimulation frequency. 7 •

8 1 0 1 1 43 46
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Pette et al. 8 investigated the time sequence of changes in time to peak twitch,
enzyme activity, myosin light chains, and fiber type in the fast twitch tibialis
anterior and extensor digitorum longus of rabbits in response to long term LFES
programs. Stimulation was delivered at I O Hz in either an intermittent protocol of
8 hours per day, or a continuous protocol of 24 hours per day, for durations of 3
to 62 days. Changes in the contractile characteristic and enzyme activity occurred
before changes in fiber myosin light chains and fiber type distribution were
discernible. All changes demonstrated a relationship with the amount of time the
stimulation was administered. In the 8 hour per day protocol, changes in light
chain pattern did not occur until after 60 days of stimulation, even though the
contractile property of time to peak isometric twitch contraction appeared after 3

16

weeks. Changes in light chains were more rapid in the continuous protocol of 24
hours a day; this occurred after 3 weeks of stimulation.
Rubenstein et al. 10 gave more insight into the changes induced in muscle
myosin and the incomplete nature of its conversion due to electrical stimulation.
Ten Hz stimulation frequency was applied to the tibialis anterior, extensor
digitorum longus, and peroneal muscles via the peroneal nerve in rabbits.
Changes in fast and slow myosin were noted in response to the LFES. With
stimulation, most muscle fibers showed the presence of both fast and slow myosin,
with progressive increases in slow and decreases in fast myosin as the stimulation
time was extended. This contrasts with the unstimulated muscles which stained
predominantly as fast twitch. The authors ascertained that the presence of both
myosin types in the muscle fiber supported the contention that pre-existing fibers
are reprogrammed, resulting in a switching of fast to slow myosin synthesis, as
opposed to the muscle being permanently programmed to be either slow twitch or
fast twitch. The incomplete conversion reported by previous researchers, and
thought by some to be due to the stimulation source being artificial, 6 was now
being considered a reflection of the transitory state of the muscle fiber.
Hudlicka et al. 46 investigated changes in blood flow, capillary density, fuel
metabolism, and endurance characteristics in fast twitch muscles of rabbits using
the previously discussed protocol comparing groups stimulated with 10 Hz and 40
Hz with a control group. The 8 hours a day stimulation for 28 days showed
increases in blood flow, capillary density, oxygen consumption during contraction,
17

and endurance, as well as a shift from anaerobic to aerobic metabolism in both
experimental groups, irrespective of the frequency of stimulation delivered.
Endurance wa s quantified by electrical stimulation as described in the previous
report by Hudlicka et al.

43

A difference was detected in lactate output, with the I 0

Hz group having lower lactate output than the 40 Hz group or the control group,
which were similar.
In the two reports by Hudlicka et al. , the authors commented on a limitation in
the use of different electrical stimulation frequencies in attempting to simulate
slow and fast motor neuron patterns.

43 46
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The I O Hz frequency wa s considered

close enough to the naturally occurring frequency found in slow twitch muscles;
however, they did not feel that 40 Hz mimicked fast motor units sufficiently, since
only an unfused tetanus contraction was produced in the muscle. The limitation
laid in the inability of conscious animals to tolerate the discomfort produced by
higher frequencies of long periods of stimulation. Even if this is regarded as a
possible limitation, the results of the study give evidence of the plasticity of a
wide array of muscle properties in response to a LFES program given over a 28
day period.
Heilig and Pette7 studied changes in enzymes in resp onse to a long term
application of a LFE S program ( I O Hz, 1 2 hours a day) on the predominantly fast
twitch rabbit tibialis anterior muscles. They found decreases in glycolytic enzyme
activity and increases in mitochondrial enzyme activity, providing evidence of the
shift from anaerobic fuel metabolism to aerobic substrate oxidation. These
18

changes in enzymatic activity pattern were considered integral to the increased
resistance to fatigue reported in muscles chronically stimulated with a low
frequency.
Heilig and Pette found that increases in some enzymes and decreases in others
began within one day of stimulation. Enzymes whose activity was increasing
reached complete transformation before those that were decreasing. Changes due
to the LFES were also documented in isoenzymes of lactate dehydrogenase
(LOH), as soon as 3 days after stimulation onset, and were offered as further
support for the capability to modify gene expression by altering the pattern of
activity of the muscle.
LFES has also been proven to alter intracellular biochemistry and membrane
potential of fast twitch tibialis anterior muscles of rabbits. 1 1 Complete
transformation of the fast twitch muscle to slow twitch muscle was confirmed
after 5 weeks of continuous 8 Hz stimulation. After the LFES program, increases
also occurred in intracellular sodium with commensurate decreases in intracellular
potassium. No change was observed in intracellular magnesium, but a transitory
increase in intracellular calcium was noted which returned to normal by 2 to 3
weeks of stimulation. Membrane potential also decreased in line with a fast to
slow transformation. Of particular interest in this study was the temporary nature
of changes in intracellular sodium and potassium, and in the membrane potential,
after cessation of the stimulation. Many previous studies had documented a
return to fast twitch muscle contractile characteristics, myofibrillar proteins, and
19

enzymatic activity, within several weeks after the stimulation had been terminated.
In marked contrast to the time course of these changes, intracellular sodium,
potassium, and membrane potential began reversal to their original fast twitch
levels within 1 0 minutes after stimulation ceased, and were complete within 3 0
minutes. The resear�hers offered this finding as proof that long term low
frequency electrical stimulation does not cause any membrane damage.
Some discussion in the literature occurred over where and what type of
morphological transformation was transpiring in the stimulated muscles. After
reviewing the results of many research investigations, Salmons and Henriksson 47
noted that the preponderance of evidence indicates a transformation of fast twitch
to slow twitch occurs within each fiber, as opposed to hypertrophy of slow twitch
fibers with commensurate degeneration of fast twitch fibers. Several tenants for
this conclusion are enumerated by the authors, with the incomplete nature of the
conversions in histochemical, biochemical, and physiological properties being a
major contributing factor.
Debate over when a transformation represents a change from Type II fibers to
Type I fibers as opposed to Type lib to Type Ila also emerged. Mabuchi et al. 4 8
investigated the fast to slow twitch muscle property changes associated with
intermittent LFES in comparison to previous changes documented in continuous
LFES. They claimed that previous studies of intermittent LFES had documented
changes primarily in metabolic enzymes, but not in myosin light chains sufficiently
enough to indicate changes from Type II to Type I fibers. Mabuchi et al.
20

contended that a LFES program of 1 0 Hz, 8 hours a day for 7 weeks, resulted in a
transformation of Type II subtypes, from Type lib to Type Ila. These changes in
myosin subunit structures of Type II fibers were seen as an intermediary stage in
the fast to slow transformation, and were a result of the intermittent stimulation
pattern.
In a subsequent review paper, Pette9 questioned the meaning of classifying
fibers into subtypes of Ila and lib when they are in a transformation process. In
general, he queries the idea of fiber type classification altogether. In this 1984
publication, Pette9 updates his 1976 report, 8 and details the sequencing of events
in the transition of fast twitch to slow twitch muscles in animals due to the
increased contractile activity imposed by electrical stimulation. Initial changes in
contractile characteristics are due to changes in the release and uptake of Ca 2+ due
to alterations in the sarcoplasmic reticulum. Commensurate with this, metabolic
enzymatic activity changes cause an increase in aerobic oxidation capacity and a
decrease in anaerobic glycolytic capacity. Changes in LDH also occur in this
stage. The resultant increase in mitochondria causes a white to red
transformation. Total ribonucleic acid (RNA) activity is seen to increase with
stimulation until plateauing after four weeks of continuous stimulation. Finally, as
electrical stimulation continues, changes in the myosin subunits, or light chains,
occur. At this time, histochemical staining indicates a conversion of Type II to
Type I. Pette does not specifically address changes in muscle fatigability, so it is
not known for certain where this muscle property may fall on the spectrum. Other
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researchers have reported changes in muscle fatigue in response to tetanic
stimulation simultaneously with changes in contractile prop erties. 1 4 • 1 5 •43
Pette emphasizes that such an orderly sequencing of events due to the
stimulation is much more indicative of a transformation of one fiber type as
opp osed to the exchange of one fiber type for another. As a result of all of the
above changes in the multiple systems of the muscle, the muscle is viewed as an
extremely adaptive tissue in resp onse to demand. Increased activity, as imposed
by a LFES program, is considered to induce an alteration in the muscle from fast
twitch characteristics to slow twitch characteristics.
Dangain and Vrbova 25 examined the effects of a LFE S program on diseased
muscles. A protocol of I O Hz stimulation was delivered to normal and dystrophic
mice. The greatest increase in force output after stimulation was seen in the mice
that were the weakest initially. Similar to the findings of Hudlicka et al. 43 in
rabbits, the strongest mice showed an initial minor and transitory decrease in force
output. This was considered by the authors to be due to a replacement of
contractile proteins by mitochondria.
Thus far, much of the animal research had been predominantly focused on
changing fast twitch muscle to slow twitch muscle by using electrical stimulation
in a frequency and pattern of activity which imitated that normally delivered to
slow twitch muscles. The transformation had been documented by a multitude of
muscle prop erties such as contractile characteristics, resistance to fatigue, fiber
type, enzymatic activity, myosin light chains, and intracellular chemistry.
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The reverse procedure, inducing change in �uscle properties from slow twitch
to fast twitch posed a greater challenge to research technique, and most probably,
was influential in directing the focus of future research as it progressed into
human models. The technical problem arose in trying to completely eliminate the
normal input to the muscle, which would be required to remove the slow motor
neuron influence.

4

9

Stimulation at a higher frequency, e.g., 60 Hz, had been

shown to result in a fast to slow transformation even though a phasic pattern of
stimulation had been applied, since the overall pattern of activity imparted to the
muscle was high.

1

2

To test an intermittent phasic stimulation pattern mimicking a

fast motor neuron, all other neural inputs must be controlled, or more specifically,
silenced. This could be done by cross innervation, 3 denervation, 6 • or
50

tenotomy. 4'
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An obvious limitation exists in applying these methodologies to

human subjects. Another limitation with human subjects is the cutaneous
discomfort experienced by the subject when using a higher frequency of
stimulation. Most likely, these technical limitations guided future research with
human models leading to the use of 30-50 Hz for short term applications of 30
minutes or less, 26•

• 2

51 5

and 8-15 Hz for longer stimulation durations.

'

•

1 4 1 5 20

LFES Research in Human Models

In 1976, Peckham et al. 2 8 was one of the earlier researchers to investigate
muscle contractile changes in human subjects in response to electrical stimulation.
An electrical stimulation frequency of 10-15 Hz was applied for 2 5 weeks to the
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finger flexors of 1 2 subjects with quadriplegia. Ten of the subjects had electrodes
implanted under the skin and into the muscle belly, while the other two used
transcutaneous electrodes. Significant increases in contractile force and
endurance were rep orted in response to the electrical stimulation testing
methodologies used in the study. It may be erroneous to ascribe all of the noted
increase in these measurements to the electrical stimulation because all 1 2 of the
subjects were less than one year post injury, leaving sp ontaneous recovery as a
possible confounding factor in strength and endurance increases. No control
group was provided.
Edwards and colleagues 14 investigated changes in the adductor pollicus muscle
of two healthy subjects in response to I O Hz stimulation applied transcutaneously,
3 hours a day for 6 weeks, using a small portable stimulator. Fatigue testing was
accomplished by recording the decrease in muscle tension which occurred in
response to a sequence of brief trains of 40 Hz stimulation. A ratio of muscle
tension produced at 3 minutes compared to the initial tension was taken as the
fatigue index. Increases in the fatigue index, representing an improvement in
muscle endurance, was one indicator used to document a conversion to slow
twitch muscle properties after 2 to 3 weeks of stimulation. The researchers
prop osed that these changes were due to alterations in fiber typ e composition;
however, histological fiber typing was not performed.
Dubowitz et al. 15 used the above methodology to establish force-frequency
curves and fatigue indexes for the extensor digitorum longus and tibialis anterior
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muscles in four healthy adult female subjects. Low frequency stimulation of 8- 1 o
Hz was applied for 1 hour, 3 times per day, for 6 weeks. Results indicated a
highly significant (p=. 0 1) improvement in the fatigue index. Neither Edwards et
al. 1 4 or Dubowitz et al. 15 found changes in maximal voluntary contraction from the
stimulation program, but both groups of researchers concluded that the contractile
properties of human muscles were amenable to change via a long term LFES
program.
Scott et al. 1 6 applied LFES (8- 1 0 Hz, 3 hours per day, for 6 weeks) to the
tibialis anterior muscles of 1 6 adults and 1 8 children. The fatigability of the
muscle was measured using the 40 Hz stimulation testing protocol. Although the
results demonstrated a significant reduction (p<. 0 1) in the fatigability of muscle in
adults, improvement in the muscle endurance was not noted in the children. They
concluded that the properties of adult human muscle could be altered by a LFES
program, and that it could potentially benefit patient populations with
neuromuscular disease.
Rutherford and Jones20 stimulated the adductor pollicus and first dorsal
interosseus in 1 0 healthy human subjects using a small portable stimulator with
transcutaneous electrodes. Electrical stimulation testing methods were used for
quantifying changes in muscle contractile characteristics and fatigability.
Maximum voluntary contraction was used to assess strength changes in the
muscle. The stimulation protocol was similar to previous studies in that it was
applied for 3 hours a day for 6 weeks; however, two stimulation patterns were
25

used in this evaluation. One group of five subjects received a uniform 10 Hz
stimulation frequency as in the previous reports, while the other group of five
subjects received a non-uniform pattern of 10 Hz stimulation interspersed with
bursts of 5 0 Hz frequency (10 every 6 . 5 seconds). Both groups demonstrated an
improvement in fatigue resistance in the stimulated muscles; the researchers
attributed this to an increase in capillary density and oxidative enzymes. One of
the more notable findings in the study was the difference in maximal voluntary
contraction between the two groups. The uniform 10 Hz stimulation frequency
resulted in a slight decrease in the maximal strength output; this decrease in
maximal strength was not noted in the non-uniformly stimulated group. The
investigators stress�d the clinical importance of the non-uniform pattern for
individuals whose muscle strength may be weakened by disease.
Scott et al. 17 developed a protocol for children with muscular dystrophy in
which a LFES program of 8 Hz, 3 hours per day, 6 days a wee_k, for 7 to 11
weeks was applied to the quadriceps muscle. Maximal voluntary contraction was
assessed, as well as electrical stimulation testing of resistance to fatigue. Small,
but significant increases in strength resulted from the children receiving 10 weeks
of LFES. This may be an extension of the concept introduced by Dangain and
Vrbova 25 in dystrophic mice which suggested that a greater likelihood of strength
increase may occur in muscles that are initially weak. Support for this may also be
represented in the research results of Peckham et al. 28 on individuals with
quadriplegia. LFES may promise increases in strength to the weakest clinical
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populations that stand to benefit from it most, whether the weakness is from a
peripheral muscular disease, such as muscular dystrophy, or a central nervous
system (CNS) lesion such as quadriplegia.
The findings of Scott et al. 1 7 relating to muscle endurance merit discussion.
Although resistance to fatigue was measured by electrical stimulation testing at 40
Hz as seen in other studies, most of the children in the study did not tolerate this
testing protocol because it was too uncomfortable. In the five children that did
complete the testing, no changes in the endurance of the muscle were indicated by
the fatigue index. There are some plausible explanations for this result. One
possibility is that the LFES did not induce any changes in fatigue resistance of the
muscle. In an earlier study by Scott et al., 1 6 healthy children, in contrast to the
adult subjects, did not experience an increase in fatigue resistance as a result of
LFES. This may suggest that responses to a LFES program vary with age.
Another possible contention is that testing muscle contractile characteristics at 40
Hz is not the best assessment method for clinical populations, such as the children
with muscular dystrophy. Any pathological condition which increases the fat or
connective tissue in a muscle can make higher frequencies of electrical stimulation
uncomfortable because it causes an increased resistance to the electrical impulse. 27
This would become particularly apparent when a large muscle group such as the
quadriceps is stimulated. Lastly, it is also possible that the subject number of five
that was able to complete the electrical stimulation testing, did not result in
enough statistical power to detect any significant changes. The endurance
27

response of muscle to LFES requires further research in patient populations to
answer these questions.
LFES protocols involving human subjects have primarily restricted their
evaluation to the contractile properties and fatigability of muscle. Gauthier et al. 22
provide data linking the sequence of changes previously determined in animals
with corresponding changes in humans in response to low frequency electrical
stimulation. A LFES program (8 Hz, 3 hours per day, 6 days a week, for 6 weeks)
to the quadriceps muscle was evaluated for its effects on metabolic enzymes in 16
men and 10 women. As in animals, enzyme activity of the Krebs cycle, electron
transport chain, and fatty acid oxidation were significantly increased after the
electrical stimulation program. No changes occurred in enzymes associated with
glycolytic pathway activity.
As reported earlier by Pette 9 in 1984 on animal subjects, changes in the
enzymatic activity and contractile characteristics occur in conjunction with total
RNA activity, and are a precursor to histological demonstration of fiber type
changes. One of the first studies to demonstrate changes in fiber types as a result
of a LFES program was by Martin et al. 24 in 1992 . Muscle biopsies performed on
the tibialis anterior muscle of spinal cord injured subjects showed average
increases of 25% of Type I muscle fibers after 24 weeks of stimulation at 20 pps.
Th� protocol called for gradually increasing the stimulation duration in 6 week
increments from 45 minutes initially, to 8 hours a day the last 6 weeks. Stein et
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al. 23 also reported increases in the muscle's endurance and oxidative capacity with
this protocol.
The practical application and clinical benefits of a LFES program have not
been limited to spinal cord injuries or neuromuscular diseases. Low frequency
electrical stimulation has also been used in post-surgical rehabilitation.
Transposition of the gracilis muscle to correct anal incontinence (gracioplasty) is
a procedure that had been applied for several years but with limited success
because of the quick fatigability of the gracilis muscle. Baeten et al. 29 and Konsten
et al. 30 used a LFES program to transform the muscle properties of the gracilis
from that of fast twitch to that of slow twitch. In the reports by these researchers
the percentage of Type I muscle fibers increased from 44% to 63 % after 16 weeks
of stimulation at 25 Hz frequency. Tremendous functional improvements were
also reported by the two research teams. Not only do Baeten et al. and Konsten et
al. document fiber type changes due to LFES, but also the results of their studies
demonstrate· the viability of LFES as a therapeutic tool in clinical rehabilitation.

Justifica tion for Further Clinical Application of LFES

The present body of knowledge supports future inquiry into the potential
therapeutic effects of LFES in patient populations for increasing muscle
endurance, and possibly, muscle strength . LFES would seem to be advantageous
in pathological conditions typified by a conversion to, or preponderance of, Type
II muscle fibers since it induces the expression of slow twitch muscle
29

characteristics. Benefits from a LFES program could include a reduction in the
fatigability in the stimulated muscle. Much attention in the literature has been
directed towards discerning if particular diseases occur in association with
specific fiber type atrophy or proliferation. In 1970, Edstrom 3 reported a
5

decrease in Type II muscle fibers in individuals with upper motor neuron lesions
such as cerebral vascular accidents, Parkinsonism, and spinal cord injury. More
recent literature reviews expressed a consensus of Type I to Type II fiber
conversion, with commensurate decreases in functional strength and endurance, in
conditions of paralysis (whether from spinal cord injury or other causes),
immobilization, or weightlessness.
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A review by Gordon and Pattullo
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explains that the earlier conclusion of Type II atrophy was the result of
researchers counting fibers as Type I when their phenotype had actually changed
to Type II, although their size remained small like a Type I fiber. Goldspink et
al. 3 have postulated the existence of a "default" myosin gene resulting in the
5

expression of Type II muscle characteristics under conditions of altered use,
irrespective of etiology. According to this theory, muscle fibers in the absence of
stretch and certain mechanical stimuli, revert to the expression of the fast myosin
gene leading to a greater Type II fiber population in the muscle. Ostensibly, this
could be the case in conditions of tenotomy, spinal transections, or neuromuscular
diseases in which the input of normal mechanical stimuli is limited. Current
thought seems to consider muscle fiber type expression in pathological conditions
to be complex and variable, resulting from the interplay of many factors.
30
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Whether a muscle is a flexor or an extensor, or whether it crosses one or two
joints, affects the muscle fiber type expression. The weightbearing status, the
amount and pattern of neuromuscular activity (as in muscle spasticity), and
hormonal input also influence the expression of muscle fiber type. The general
trend is for fiber atrophy and conversion to be greater in slow twitch extensor
muscles, particularly those involved in weightbearing, than in fast twitch extensors
or flexor muscle groups.

4

9

'
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LFES may also offer potential benefit to disease processes which are non
selective in fiber type atrophy, but which result in deficits in muscular strength.
As demonstrated in the study by Peckham et al. 28 in individuals with quadriplegia,
Dangain and Vrbova 25 in dystrophic mice, and Scott et al. 17 in children with
muscular dystrophy, a LFES program can cause increases in strength in muscles
that are atrophied and weak due to a disease process.
A LFES program may offer therapeutic advantages to patient populations
based on two premises. First, in pathological conditions which result in increased
muscle fatigability, possibly due to a Type II fiber predominance, LFES may alter
the gene expression of muscle contractile properties from that of fast twitch
muscles to that of slow twitch muscles, in a manner similar to that induced by an
endurance exercise program. Second, in diseases typified by substantial decreases
in strength and functional ability, LFES may provide a viable method of imposing
contractile activity on the skeletal muscle above the individual's volitional
capability, and at a frequency that is comfortable for the individual. The low
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frequency of 8- 10 Hz or pps allows better tolerance of the electrical stimulation
current, thereby permitting more use by an individual. Reports of electrical
stimulation of higher frequencies (40 and 50 Hz) in neuromuscular conditions
have been negative in terms of subject tolerance, whether the stimulus was used in
testing muscle contractile properties, 17 or in trying to increase muscle strength as
a clinical treatment option (D. R. Sinacore, PhD, verbal communication, October
1993).
One of the current challenges involves discerning the patient populations and
disease process which may benefit from a LFES program. Children weakened by
muscular dystrophy and individuals recovering from spinal cord injury or surgical
interventions have demonstrated improvements in response to LFES. Most
probably, individuals with other disease processes could benefit from LFES as
well. Multiple sclerosis may be such a disease.

Potential Benefits of LFES for Individuals with Multiple Sclerosis

Multiple sclerosis (MS) is an adult onset progressive disease characterized by
demyelinization in the white matter of the brain and spinal cord. 32 • 33 The etiology
of the disease remains unknown, but speculation of environmental and genetic
components continue. ss Mitchell33 describes three clinical forms of the disease:
( 1) relapsing/remitting with remissions and exacerbation; (2) relapsing/progressive
with less complete recovery after exacerbations; and, (3) chronic progressive
which is typified by spinal cord and cerebellar dysfunction. This last form is
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usually a progression of the relapsing/remitting process. All forms may result in a
progressive decline in strength and functional ability, although the rate of decline
and amount of dysfunction are highly variable. Functional deficits mirror the sites
of the demyelinating lesions and ·frequently result in decreased ambulatory
capacity. Progression may be severe enough to result in a non-ambulatory
status. 34
The thrust of medical treatment has been palliative in nature, utilizing a
multitude of medications. 34 '
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Currently a new drug, beta seron, aimed at stalling

the disease progression is being marketed. Clinical offerings in terms of physical
rehabilitation have been limited to stretching and strengthening exercises
combined with training in the appropriate use of assistive devices.
Recently controlled studies quantifying the musculoskeletal and physiological
responses of individuals with multiple sclerosis have been done. 57 Armstrong et
al 36 and Ponichtera et al. 38 demonstrated that isokinetic dynamometry is safe and
reliable for testing quadriceps and hamstring muscles in MS individuals. These
studies also documented decreases in the peak torque of these muscles in subjects
with multiple sclerosis in comparison to matched healthy individuals. Chen et al. 3
used isokinetic dynamometry to establish decreases in the time-rate of muscle
tension development and muscle tension-maintaining capacity of the quadriceps
and hamstrings in subjects with MS in comparison to a matched healthy control
group. V02 max has also been shown to be significantly lower in individuals with
MS as compared to a healthy control group matched for gender, age, weight,
33
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height, and lifestyle. 58 One of the few published reports dealing with the response
of individuals with MS to a exercise treatment regimen is provided by Gehlsen et
al. 3 9 In this study isokinetic dynamometry documented changes in muscle
strength and endurance in both upper and lower extremities in subjects with MS as
a result of an aquatic exercise program.
There is a paucity of data documenting changes in histological fiber type due
to the disease process of MS. Lenman et al. 21 evaluated muscle contractile
characteristics in the tibialis anterior muscle of individuals with MS utilizing 40
Hz electrical stimulation. These investigators determined that individuals with
MS show a greater fatigability and an increased half-relaxation time in the tibialis
anterior muscle when contrasted with healthy subjects. Based on these contractile
properties, the researchers suggested that the prolonged disuse associated with
MS changed fatigue-resistant fibers into fatigable ones. This finding would
concur with the literature consensus previously discussed which contends that
CNS lesions most likely result in a conversion from Type I to Type II fibers. It
may also be in accordance with the suggestion of Goldspink et al. 35 of Type II
fibers being present as a result of default myosin gene expression in response to
the normal mechanical input being altered.
Without muscle biopsy and histological fiber typing data, a definitive alteration
in muscle fiber type in association with MS can not be known. The fiber type
morphology most likely varies according to the multiple factors previously
introduced as being influential in determining fiber type expression in disease
34

processes such as spasticity, weightbearing status, flexor or extensor muscle
status, and hormonal input.
What is known is that in individuals with MS there are documented decreases
in muscular strength and endurance2 1 •36-3 8 and, ultimate functional disability. 3 4 •5 6
Resistive exercise programs have proven beneficial in increasing the strength of
individuals with MS that have sufficient physical ability to participate in them. 3 9
However, fewer options are available to individuals with MS whose decreased
functional strength is so great as to preclude participation in such resistive
exercise training. For this group of individuals with MS, a LFES program may
offer an alternative method of imposing increased activity upon the muscle. The
increased muscle fatigue documented in MS individuals2 1 • 3 7 • 39 may improve with a
long term LFES program by modifying the expression of muscle contractile
characteristics from that of fast twitch to that of slow twitch. The decreased
strength in muscles of individuals with MS
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may demonstrate an increase in

strength due to the training stimulus imposed by the electrical stimulation at a
comfortable delivery frequency.
Consideration should also be given to whether the pathological process
involved in MS makes it a viable candidate for the benefits induced by a LFES
program. LFES research has demonstrated positive results in subjects with
muscular dystrophy. In muscular dystrophy, the primary pathological process is in
the muscle tissue itself and consists of a replacement of healthy muscle fibers with
connective and adipose tissue. Muscle biopsy has not demonstrated selective
35

atrophy or hypertrophy of a fiber type, but Type I fiber predominance is
common. 59 The neural supply to the muscle is not affected in muscular dystrophy.
A case could be made that the changes induced by LFES might be able to offset
the muscle deterioration of the disease, and still have the support of an intact
neural system. Most likely this type of premise has encouraged research in this
area; however, the physiological changes proven to occur in normal muscle tissue
due to electrical stimulation may not be transferable to the diseased muscle in
muscular dystrophy.
Conversely in MS the muscle tissue is normal, but the neurological impulses
from the CNS are disrupted as a part of the pathological process. It may be less
tenuous to apply the documented changes seen in healthy muscles due to LFES to
the ''normal" muscle tissue of individuals with MS. This of course does not
negate any CNS deficit that may be present, but two principles regarding MS
should be noted. First, CNS lesions in MS can be spotty such that only part of the
neurological supply to any one muscle may be affected. There could still be
sufficient innervation intact to support some functioning of the muscle. Low
frequency stimulation may be able to maximize the remaining functional potential
of the muscle. Second, MS can be typified by remissions and exacerbations. Low
frequency stimulation may be able to fill a specific niche in the rehabilitation
process after an exacerbation by increasing the strength or functional use of a
muscle left weakened by the exacerbation. Ideally, this could be done until
volitional exercise could be initiated.
36

The purpose of this study is to evaluate the effects of a LFES program on
individuals with MS. This will be done by assessing changes in the muscle's
volitional strength and endurance in response to the protocol administered. It is
hoped that information leading to the viability of this treatment alternative for
individuals with MS will be elucidated.
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CHAPTER J
METHODOLOGY
Subj ects

With the approval of the local chapter of the National Multiple Sclerosis
Society, individuals with multiple sclerosis were recruited as potential subjects
through local multiple sclerosis support group meetings. All individuals
expressing an interest in participating in the study underwent an initial patient
history and general functional evaluation by the investigator. A standardized form
was followed for all individuals (Appendix, pp. 85, 86). This assessment helped
to discover any possible medical contraindications to the electrical stimulation
device and determined the appropriate physician to be contacted for study
participation. It also documented the type and frequency of symptoms associated
with MS, and the medicines prescribed to treat these symptoms, which provided a
basis for assessing changes that may occur during and after the experimental
treatment intervention.
After the initial history and evaluation, information letters were sent to each
potential subject's physician (Appendix, p. 87). Also included was a permission
form for each subject to be signed by the physician (Appendix, p. 88). Acceptance
into the study was contingent upon physician approval.
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Of 14 individuals expressing a desire to participate in the study, nine met all
the qualifying criteria and were admitted as subjects. Of the other five people,
two were disqualified due to medical problems, two were not allowed to
participate by their physician (the physician was the same for these two
individuals), and one lacked a definitive diagnosis of MS.
The subjects represented a continuum of possible functional disability due to
MS. They ranged from being independently ambulatory and employed full-time to
requiring maximal assistance for all mobility and personal care. Overall, six of the
nine subjects were ambulatory, including those who utilized an assistive device
such as a standard or quad cane. None of the subjects had recently begun any
exercise program or physical therapy treatment, and all subjects were asked to
refrain from beginning any new exercise programs or therapy during the course of
the study.
The subjects consisted of six females and three males, ranging in age from 3 0
years to 64 years (average age, 46 years; median age, 46 years). The years since
disease diagnosis ranged from 3 years to 20 years (average, 8 1/2 years; median, 8
years). Six of the nine subjects considered their disease classification as the
chronic progressive form, while the other three reported having remissions and
exacerbations. The most recent onset of an exacerbation was 4 1/2 months prior
to the beginning of the study. The number of prescription medications for each
subject varied from zero to nine. The most recent introduction of any new
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medicine was approximately 3 weeks prior to study onset. Of the nine subjects,
only one was currently on the newly marketed beta seron drug.

Procedure

General:

All subjects read and signed an informed consent document

(Appendix pp. 89, 90) prior to any testing. Each subject was first seen in the
clinic to obtain initial strength and endurance measurements · of both quadriceps
femoris muscles. This was followed by the application of the portable
neuromuscular electrical stimulator to be used at home for 6 weeks on the
quadriceps muscle designated as the experimental leg. Following the 6 weeks of
home stimulation, each subject returned to the clinic for final assessment of both
quadriceps femoris muscles' strength and endurance. Strength and· endurance
measurements were performed on an isokinetic dynamometer (Cybex II).
Calibration of the machine was performed before the initial testing sessions and
prior to the final testing sessions in accordance with the Cybex Systems
Handbook.

Pre-treatment Testing: Each subject was scheduled for two initial testing
sessions in the clinic separated by 4 days or less. In each session, the same muscle
testing procedure was followed. This dual testing format_ is in accordance with
the suggestion of Armstrong et al. 36 Their research indicated that a

40

familiarization session reduced the variability in isokinetic dynamometry
measurements due to extraneous factors in subjects with MS.
In the first testing session of the first subject scheduled, a coin flip determined
whether the right or left leg would be tested first on that subject. For each
subsequent subject, alternating right and left legs were tested first.
Subjects were seated on the Cybex II isokinetic dynamometer so that the
appropriate leg could be tested first. A testing data sheet (Appendix, p. 9 1) was
used to record the date, time, temperature, and calibration date of each testing
session, and to annotate the necessary Cybex settings to ensure accurate
replication on post-testing. This form also provided a checklist for maintaining
standardization across all testing sessions. Subjects were seated on the Cybex
bench utilizing one back support pad. Similar to the testing procedure of
Armstrong et al. 36 with MS subjects, the mid-point of the lever arm head was
aligned with the axis of knee rotation. The lever arm length was adjusted so that
the bottom part of the ankle pad was level with the superior border of the lateral
malleolus. Extraneous movement was minimized by securing each subject with a
lap belt, knee belt, and an ankle strap. The appropriate Cybex settings for
damping, clockwise/counterclockwise, and foot-pounds scale were selected and
recorded before testing each leg.
Each subject performed three warm-up submaximal isometric knee extension
contractions with the chart paper speed on 5 mm/sec. During these contractions,
the proper operation of the Cybex was assured as well as the comfort of the
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restraints and lever arms. After a 2-minute rest, each subject performed three
maximal isometric knee extension contractions with a 5-second hold, again with
the chart speed on 5mm/sec and 2-minute rest between each maximal contraction.
For each maximal isometric contraction, the subject was instructed to put their
hands across their lap, and on the tester's count, to ''push up with your foot as
hard as you can and keep pushing until I say 'relax "'. The subject then switched
seating positions on the Cybex bench so that the same procedure could be done to
the opposite leg.
The first testing session of the pre-treatment testing was done prior to
applying the experimental stimulation device to allow for a quantification of the
strength differences between the two quadriceps femoris muscles of each subject.
This information was used in the second session of the pre-treatment testing to
select which quadriceps muscle would receive the neuromuscular electrical
stimulation. Starting with the first subject in the second session of pre-treatment
testing, a coin flip determined whether the weaker or stronger leg would receive
the electrical stimulation for that subject. Subsequently, weaker or stronger legs
were alternately chosen to receive the neuromuscular stimulation on all of the
following subjects. One exception was made for a subject who needed to wear
the stimulator on a specific leg due to a catheter bag on the opposite thigh.

Neuromuscular Electrical Stimulation: The Respond Select TM neuromuscular
stimulator was chosen to deliver the low frequency electrical stimulation because
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the desired electrical stimulation parameters could be programmed into the
machine. This stimulator is compact in size (6.0 inches x 3. 5 8 inches x 1. 37
inches) and relatively lightweight (7.6 ounces without batteries). The electrical
stimulation parameters desired for the 6-week home protocol were pre
programmed by the investigator. A symmetrical biphasic square wave, with 300
microseconds phase duration, was delivered at a frequency of 8 pps. The on-time
of the stimulation was 5 5 seconds and the off-time was 2 seconds. The time
required for the phase to reach peak amplitude (rise time) was 5 seconds.
After completing the second session of the pre-treatment testing, the portable
stimulator was applied to the experimental leg. This was done in the clinic and
with the subject on the Cybex machine in hopes that the force output of the
experimental leg could be measured and quantified in response to the electrical
stimulation from the portable device.
Four re-useable electrode pads were placed on the experimental quadriceps
muscle. Guidelines for positioning of electrodes were derived from a- motor point
chart (Appendix, p. 92) with minor individual adjustments made to maximize ·
muscle contraction and minimize subject discomfort. Intensity of the stimulus was
increased very gradually and limited by subject tolerance. Once a subject felt the
maximum tolerable level had been reached, an effort was made to quantify the
intensity of the stimulus by its force readout on the Cybex.
Each subject received detailed instruction in the proper operation and care of
the stimulator, and a Stimulation Progression Sheet and Time Log (Appendix, p.
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93, 94). This form guided the subject in increasing the daily stimulation time.
The first day each of the two stimulation sessions lasted 1 5 minutes. Stimulation
time was increased 1 5 minutes per session each consecutive day until a duration of
I 1/2 hours for each session had been obtained.
Subjects were instructed to increase the stimulation intensity after having
plateaued at I 1/2 hours stimulation duration. The researcher encouraged each
subject to adjust the stimulation intensity to a level which provided the strongest
visible contraction of the muscle while still being a tolerable sensation for the
individual. The time log provided space for recording clock time and dial setting
for each session, as well as room for daily and weekly comments. In an effort to
accommodate individual daily schedules, there was no specific time required to
separate the two daily sessions, nor was one specific day required to be the off
day for all subjects.
During the following 6 weeks, each subject wore the portable stimulator while
continuing with their normal daily activity. Subjects were visited weekly at their
home, or place of employment, during this 6-week period. New electrode pads
were provided and changed approximately every 1 0 days. At each visit, time logs
were checked for completion, and the desired settings were confirmed on the
portable stimulator. Proper placement of electrodes was also covered, and when
possible, electrode pads were applied by the investigator at the time of the visit.
Individual charts were maintained on each subject by the investigator documenting
the activities of each visit and any other communication with the subject.
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Post-treatment Testing: After 6 weeks of stimulation, subjects were scheduled
for two separate clinic visits to repeat the testing of both quadriceps muscles on
the Cybex. As in the pre-treatment testing sessions, three warm-up submaximal
contractions followed by .three maximum isometric knee extension contractions
with a 5-second hold were performed. Cybex settings recorded in the pre
treatment sessions were duplicated for post-treatment testing, and the same
testing protocol was followed as discussed in the pre-treatment testing. The time
of day of testing for the final session was the same as the pre-treatment testing
session.
The intensity of the electrical stimulation tolerated from the portable
stimulator was re-assessed for each subject in post-treatment testing. This was
done by obtaining a force readout on the Cybex of the muscle contraction elicited
by the portable stimulator. Each subject was instructed to increase the intensity
of the stimulation to a level which caused a muscle contraction commensurate
with the strength of the muscle contraction they had been performing at home. All
subjects used the portable stimulator until the day of the second session of post
treatment testing, but not the day of the second session post-treatment testing.
A follow-up questionnaire regarding the electrical stimulation protocol was
mailed approximately 2 weeks after the study's completion to determine the
subjective responses of the subjects to the protocol (Appendix, p. 95, 96).
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Statistical Analysis: Each maximal isometric contraction with a 5-second hold
yielded three indices of muscle performance: peak torque, mean force, and fatigue
slope. Peak torque was the highest torque obtained in the contraction and was
designated fp on the Cybex graph, occurring at time of peak torque, tp. Mean
force was the arithmetic average of force from the time of peak torque (tp) to the
end of the 5-second hold (ts) inclusive, with force readings taken every .5
seconds. The next to the last force reading taken for averaging was no less than
.2 seconds from ts. Fatigue slope was calculated according to the following
formula:

Fs =

fi, • f, X 100
fp

In this formula, fatigue slope is Fs and is expressed in %/sec units; fp is the
peak force; f5 is the force at 5 seconds; ts is the 5-second time mark; and, t p is the
time of peak torque. All Cybex readouts were initially in foot-pounds and
converted to newton-meters.
The average of each of the above three indicators was computed from the
three maximum isometric contractions giving the dependent variables of average
· peak torque (APT), average mean force (AMF), and average fatigue slope (AFS).
Utilizing the data from the second session of the pre-treatment testing, the
experimental legs and the control legs were compared in an analysis of variance
(ANOVA) with one within subject variable to ascertain the similarity of the two
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groups. The data from the second sessions of the pre-treatment and post
treatment testing were used in the statistical analysis for determining the effects of
the treatment. For each dependent variable, a two-way ANOVA with two within
subject factors was performed. The within subject factors were time, represented
by two levels of pre- and post-test results, and group, representative of the two
levels of either the control or experimental leg. The null hypothesis was that the
LFES would not cause a significant change in these three variables over time for
the experimental leg compared to the control leg. Statistical significance was set
at .05.
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CHAPTER 4

RESULTS

The ANOVAS comparing the initial values of the dependent variables average
peak torque (APT), average mean force (AMF), and average fatigue slope (AFS)
for the experimental legs compared to the control legs are displayed in the
Appendix (p . 97). Prior to the application of the electrical stimulation program,
experimental and control legs were not statistically different for APT (p < . 6365),
AMF (p < . 75 62), or AFS (p < . 4732).
Table I shows the increase(+) or decrease(- ) in the experimental and control
legs for each of the three dependent variables. From this table, the variability in
response to the LFES is easily recognized. Subjects one, two, three, and five each
demonstrated a different response pattern for the experimental and control leg on
the measures of peak torque and mean force. In contrast, for fatigue slop e most
subjects demonstrated a decrease in muscle fatigability for both the experimental
and the control leg. The raw data is also available for inspection in the Appendix
(p . 98).
The ANOVA summary tables for treatment effects of all three dependent
variables, and the simple effects for AMF, are found in the Appendix (pp . 99,
1 00 ) . APT did not reveal statistical significance at the .05 probability level for
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Table 1 . Increase(+) or Decrease(-) in Experimental vs Control Leg

Sub.iect 1

Avg Peak Torque. Avg Mean Force
(change in Nm)
(change in Nm)
Control
Control Exp
Exp
-5. 12
-6. 32
-2. 29
-6. 3
-. 18
+3 . 14
-3 . 85
+2. 49
+9.07
+ 10. 49
+6. 1 3
+9. 72
+. l
+ 12.08
+4. 3 1
+ 12.03
+7. 46
-5.48
-5.65
+8.92
+3 8. 19 + 13.56 +3 3 .93 + 1 1.55
+5. 44 + 12. 83
+5. 3 8 + 12. 89
+2.63
+4.25
+2.52
+4.43
+2 8.92 + 1 1.97 +26.66 + 12. 12

Avg Fatigue Slope
( chanJ?; e in %/sec)
Exp
Control
-5.53
-. 1 1
- 1.66
-. 33
- 1. 44
-4. 24
-4. 39
- 1.05
3.27
+ 1. 1 7
-5. 84
-2.06
-.02
-. 3 8
-5.68
-3. 5
+.92
- 1. 78

either time (p< .0566), group (p < . 8390), or time/group interaction (p < . 1073).
However, inspection of the graph of the interaction in Figure 1 suggests a possible
trend for increasing peak torque for the experimental group above that of the
control group.
AMF statistical significance occurred for time (p < . 025 1), but not for group
(p < .9635), or time/group interaction (p < .0985). As for APT, graphing of the
time/group interaction for AMF (Figure 2) demonstrates the interplay of time and
group suggesting a greater increase in mean force for the experimental leg than
the control leg. Simple effects demonstrated significance of time on the
experimental leg (p < .027), but not for the control leg (p < .065) (Appendix,
p. 100). For both APT and AMF, the large standard error of the mean (SEM) bars
depicted on the graphs also show th� variability in subject response.
Six out of nine subjects increased the APT and AMF on both the experimental
leg and the control leg, most often with greater increases occurring on the
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Figure 2. In teraction of time and group for Mean Force
with stan dard error of mean bars.

experimental leg. The average increase in APT for experimental and control legs
was 37. 59% and 1 9.4 8%, respectively. The average increase in AMF was 3 9 . 99%
for the experimental leg and 26. 73 % for the control leg.
The dep endent variable average fatigue slope was significant for time
(p<. 034 8), but not for group (p < . 3 3 25) or interaction effects (p < . 83 8 1 ). The
graphic depiction in Figure 3 demonstrates a decrease in fatigue slop e for both
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experimental and control legs. The SEM bars indicate wide subject response
variability for this variable as well.

8
7
AFS (0"8ec)
5
4

post

pre

Figure 3. Response of time and grou p for Fatigue Slope
with standard error of mean bars.

The stimulation intensity tolerated by the subjects increased during the six
weeks that the stimulation was used. During pre-treatment testing, six out of nine
subjects were either unable to elicit a measurable contraction on the Cybex
induced by the portable stimulator, or the force readout on the Cybex was less
than 1 % of the average maximum voluntary isometric contraction (MVIC)
measured for that subject. At pre-treatment testing, the range of muscle force
produced by the portable stimulator ranged from O to 4. 53 % MVIC with an
average of . 83 % MVIC.
At post-treatment testing after 6 weeks of stimulation, only one of the nine
subjects produced a muscle contraction force less than 1 % MVIC in response to
the portable stimulator. One subject was considered an outlier eliciting a
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contraction that was 137. 66% of MVIC. Disregarding this person's data, the
range at final testing was .53 % to 18.22% MVIC, with an average of 6.42%
MVIC, demonstrating a good increase in stimulation intensity tolerance.
In summary, as a result of the statistical analysis using the pre-determined . 05
probability level for significance, the decision is to not reject the null hypothesis
that this LFES program has no effect on the strength and endurance of the
quadriceps muscle in the multiple sclerosis individuals.
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CHAPTER S

DISCUS SION

In discussing the outcomes of this study, consideration will be given to the
clinical trials nature of the research design followed by an in depth assessement of
the statistical results for each of the three dependent variables, including the
conclusions which can be drawn in reference to the initial research question. The
results of the exploration of the data for possible response patterns will also be
covered.

Clinical Trials Nature of the Study

The clinical nature of this study provided a framework for planning the
research protocol, and its influence should be considered when the results of this
study are assessed. A main objective of the study was to examine a clinical
treatment protocol in a specific patient population under "real world" conditions.
This goal of the study molded aspects of the research design specifically in
regards to the selection process for subjects, and the decisions of which indices of
performance would be used. The clinical trials nature of this study also allowed
the inclusion of numerous extraneous variables for which experimental control
could not be enforced. In the following section, the clinical trial aspect of the
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study as it relates to components of the research design, including the extraneous
variables of the study, will be discussed. The influence this exerted on selecting
the appropriate statistical analysis will also be considered.

Research Design Aspects:

The objective of this study was to examine the effects

of a LFES program in a clinical population. This permitted subject selection to
include individuals with multiple sclerosis which represented a broad range of
functional disability. Although previous studies involving multiple sclerosis
limited subject selection to ambulatory subjects,

3

6

'
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by the inclusion of a wider

span of subject functional levels, not only would this increase the external validity,
but also it would allow for the revelation of any response patterns. Trends in
responses were inspected for their correlation with certain subject traits, such as
initial strength level, or stimulation intensity tolerated, and will be discussed later
in 'Exploration of the Data '.
One objective of the research design was to obtain the most valid
representation of each individual's muscle performance at each testing session.
To accomplish this, the responses of each variable across the three contractions
were averaged, for this may provide a more true and consistent indicator of
individual performance. This.is particularly applicable for subjects with a disease
typified by variation. The unfamiliarity of the subjects with testing equipment
such as the Cybex also supports averaging of responses.
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The decision of what indices to use for representing muscle strength and
endurance was also guided by clinical practicality and applicability. The maximum
voluntary isometric contraction has been commonly used as an indicator of muscle
strength on healthy subjects,

6

0' 6 1

and for subjects with pathologies.

• 0 •3 9

16 2

Quantifying the muscle's endurance capability is more elusive. As noted in the
literature review, many studies investigating the effects of a low frequency
electrical stimulation program on animals and humans have taken the muscle's
force decrease in response to a train of electrical impulses at 40 Hz as an indicator
of the muscle's endurance.

' 7 '2 1 '3 1

16 1

However, as noted by D. S. Stokic, MD, a

researcher at Baylor College of Medicine in Houston, Texas, (verbal
communication, February 1994), published studies have yet to prove that
electrically induced fatigue has any correlation to the volitional performance of
the muscle. In terms of performance criteria, Gehlsen et al. 9 quantified endurance
3

in the quadriceps muscle of MS individuals by calculating the percentage of peak
torque decline that occurred in 50 isotonic knee extension/flexion contractions at
180 degrees/second on the Cybex. This methodology provides a good indicator of
performance fatigue; however, this level of physical activity exceeded the
capability of several of the subjects in this study, and of many other patients that
might be encountered in a clinical setting. Chen et al.

3

7

also assessed muscle

endurance in individuals with multiple sclerosis by using a voluntary isometric
knee extension contraction with a 5-second hold. Endurance was represented by
the tension-maintaining capacity (TMC) of the muscle. This was calculated by
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counting the squares in the area under the torque curve of the Cybex printout.
Although this procedure could be applied to all subjects in this study, in practice,
this technique does not always provide a consistent indicator of muscle endurance.
A Cybex curve with an extremely high initial peak torque, but one which drops off
rapidly, could easily give a higher TMC score than a curve which maintained a
consistent force across the 5-second hold. The initial height of the curve could
encompass more squares than that which would be included in a consistent,
maintained force read out.
To overcome some of the above problems, three indices of performance were
decided upon which were derived from the Wingate Anaerobic Test. 62• 63 The
measurement of peak torque is similar to Wingate's peak power index and is taken
to represent the maximum strength capability of the muscle. The Wingate test
utilizes a "rate of fatigue" or the slope of the line from the highest to lowest
torque. In this study, the fatigue slope index is calculated to represent the overall
rate of force decline from peak torque to the torque produced at the 5-second
mark. It is considered a measurement of muscle endurance. Lastly, the mean
force of the quadriceps muscle is the arithmetic average of force produced over
the 5-second hold in the maximum isometric knee extension contraction. This
measurement equates to the mean power index of the Wingate 30-second test. In
this study, the mean force measurement is considered to represent a combination
of the functional strength and endurance of the muscle. All three indices can be
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obtained from an isokinetic graph print-out, which makes this assessment
technique readily accessible to most clinicians.
Determining which index, mean force or fatigue slope, constitutes a better
representation of the muscle's endurance performance is debatable. The fatigue
slope gives an overall picture of the force decrement in the muscle for the 5second hold. However, in disease processes like multiple sclerosis, which is
typified by a fluctuating force response on the Cybex, 37 calculating the mean force
with force readouts every . 5 seconds may provide a better indicator of the
muscle's endurance, and be more sensitive to changes in endurance in response to
a treatment.

Extraneous Variables: The clinical trials nature of the study also allowed
several uncontrolled variables to be present in the study. Some of these variables
were tied to the methodology of treatment implementation such as subject
compliance, motivation, and seasonal changes in strength. Others were related to
the varied functional levels of the subjects, to fluctuations inherent in the disease
process of MS, and to medications taken by the subjects.
One of the most common sources for variation in a home program revolves
around subject compliance to the program. Each subject completed a daily log
which indicated exceptional compliance. The Respond Select portable stimulator
is equipped with a time compliance feature which allowed the investigator to
monitor how much the machine had been used. However, the information
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provided tells only the hours of operation for the machine since the device was
last zeroed. It cannot be determined whether the machine was actually applied to
the body or simply turned on. Moreover, it cannot judge whether the device was
correctly applied to the body by the subject, or to the appropriate part of the
body. It does however provide some insight into the actual usage time as
compared to reported time, since the retrieval of this information is not readily
apparent to the subject.
To assist in confirming that changes in the muscle were due to the treatment,
periodic checks of the timer function were annotated and comp ared with the time
requirement of the daily log. Inspection of this information indicated 1 00%
compliance in five subjects. Compliance for the other four subjects was 9 1 %,
73%, 66%, and 6 5 %, resulting in an overall compliance average of 88%. The data
results for the two subjects with the two lowest compliance times did not
represent any substantial trend differences from the other subjects. It is important
to realize that the information was not collected with the accuracy suitable for
statistical analysis, but only for the purposes of establishing general trends. The
information provided by the stimulator, in conjunction with the app arent
motivation of the subjects, suggests that compliance was good overall.
Subject motivation played another role in the study due to the obvious nature
of the treatment program, and its interaction with the dedication of the subjects to
find a beneficial treatment option. The primary reason expressed by each subject
for participating in the study was the desire to help themselves and possibly other
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people with MS. This, combined with the conspicuous nature of the treatment
application, necessitates the inclusion of a possible Hawthorne effect in the results
of post-treatment testing.
Another confounding variable relates to the time of year in which this study
spanned. The 6 weeks from pre-test to post-test transpired from mid-spring to
early summer and coincided with a general trend for increased physical activity
among several of the subjects. The increased activity could cause an improvement
in muscle contractile characteristics not due to the electrical stimulation program.
This may explain why six out of nine of the subjects had increases in average peak
torque and average mean force on both experimental and control legs. Also, the
subjects which were more active and who became busier with the improving
weather, reported having more difficulty finding the time to do the 3 hours a day
of electrical stimulation. Initially, there was concern that warming temperatures
may adversely effect the post-treatment measurements due to the heat intolerance
often experienced by individuals with MS. This prompted the recording of inside
and outside temperatures at pre- and post-treatment sessions. In actuality,
subjects did not feel that the increased outside temperature resulted in poorer
post-treatment performance, as adequate rest time in an air conditioned
environment was provided.
Uncontrolled sources of variation also resulted due to the subjects having a
ongoing disease process. The erratic disease progression and individual variation
in symptoms due to MS pose a particular challenge for research design. As
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expected, individuals in transition from a remission or exacerbation make
assessment of treatment changes difficult; but the more subtle and persistent
fluctuations in daily, or even hourly performance, present as much of a problem in
evaluating outcomes. Details such as time of day of the testing, testing
temperatures, and previous activity the day of testing, can probably be more
influential in affecting the performance response of subjects with MS than
"healthy normal" subjects.
It is not surprising that each subject had different tolerance levels for the
electrical stimulation intensity; however, one subject's ability to tolerate the same
stimulation level was markedly altered during the study' s course. This subject
reported an increasing sensitivity and unpleasant sensation from the stimulation
during the fourth to sixth week of the stimulation program. Commensurate
decreases in functional ability, and increases in muscle spasticity, motivated the
subject to request advice from her physician. Although a causal relationship can
not be known for certain, the alteration in sensitivity occurred in conjunction with
a progressive imbalance in the subject's magnesium, potassium, and calcium,
which was detected by this medical evaluation. The biochemical alteration was
considered most likely to be secondary to a medication being taken.
Medications taken for controlling symptoms associated with MS may also
contribute a great deal to uncontrolled variation in this type of research. In the
present study the number of prescribed medications taken by subjects ranged from
zero to nine. Although acceptance into the study prohibited having just started
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any new medication, adjustments to doses, or pharmacological treatment of
specific problems during the study, could not be obviated. One subject required
an increase in anti-spasticity medicine, while another required five days of
intravenous cortisone therapy to improve a decline in visual acuity. Both of these
instances represent the need for continual adjustment in the medical treatment
required to meet the ever changing physical and physiological state imposed on
the body as a result of MS. This type of variation can not be reasonably
controlled in either a research scenario or a clinical environment.

Selection of Statistical Procedure: All of the above extraneous variables
contribute to form tremendous between-subject and within-subject variability.
The desired statistical procedure needed to be able to control for changes within
each subject, such as fluctuations in performance and changes in medications, and
to avoid the inflated significance which may occur if multiple paired t-test
comparisons are used. The methodology considered to be most sensitive in
extricating the changes in muscle characteristics attributable solely to the low
frequency electrical stimulation program was an analysis of variance with two
within subject variables.
From the foregoing discussion, the clinical nature of the research design has
been considered for its impact on the study's methodology, and on the selection of
the statistical procedure. It will be considered further in the following section for
its relationship to the statistical results of the dependent variables.
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Assessment of Statistical Results
The results of this study did not conclusively demonstrate the muscle
performance changes that were expected as a result of a LFES program. In
contrast to the findings of much of the previous research, statistical significance at
.05 was not achieved for the indicators of muscle strength, average peak torque
(APT) and average mean force (AMF), or for the indicator of muscle fatigue,
average fatigue slope (AFS). Possible reasons for this are discussed below.

APT and AMF: Both of these variables came close to the pre-determined
significance level of .05 demonstrating a possible interaction between time and
group (APT, p<. 1073 ; AMF, p<.0985). Two factors in this study may have
limited the complete expression of this trend of increasing strength for the
experimental leg.
The first factor relates to the 6-week duration of the treatment application.
Pette et al. 8 and Rubenstein et al. 1 0 emphasized the incomplete nature of the
conversion of muscle traits from fast to slow twitch in the predominantly fast
twitch muscles of rabbit. The degree of changes was related to the length and
duration of the stimulation program. In animal models demonstrating changes in
muscle enzyme activity and contractile characteristics, stimulation frequencies of
8- 10 Hz were generally delivered 8 to 10 hours a day for at least 3 weeks before
initial changes were documented in the muscle properties. 1 •
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in human subjects, when the daily stimulation time is reduced to 3 hours a day, a
longer than 6-week duration is needed to produce the same contractile changes in
the muscle. The 6 weeks of this study may not have been sufficient for permitting
these changes to be expressed. The trend toward increasing mean force over time
for the experimental leg supports the contention that a longer program may have
demonstrated statistically significant changes on this measure.
The second factor, and probably the most influential, relates to the clinical
trials nature of the research design. As discussed earlier, this incorporated many
extraneous variables into the study and made obtaining statistical significance at
.05 with a subject number of nine very difficult. According to the equations and
tables set forth by Kraemer and Thiemann, 64 for nine subjects with the critical
effect size present in this study, only a 40% chance of detecting a significant
change existed for a two-tailed test at .05 significance level. For this reason, the
results of this study may warrant a more generous approach than that allowed by a
pre-determined . 05 alpha level.
Franks and Huck65 make a strong argument for using significance levels of . I 0
or greater in studies which meet certain research criteria. Studies that are
exploratory in nature and that employ a small subject number are encouraged to
use significance levels higher than the traditional cap of .05. Both of these
criteria are contained in the present study. Further, Franks and Huck specify the
use of a higher alpha level to be particularly appropriate when the consequences
of a Type II error can be considered more costly than that of a Type I error. A
63

Typ e II error in this study would mean accepting the null hyp othesis that electrical
stimulation has no effect on muscle strength or endurance in multiple sclerosis
patients, when in fact, it does have an effect. The consequences of such an
erroneous acceptance could deprive a patient population from having a viable
treatment option uncovered through future research. This could be considered
costly. Conversely, a Typ e I error in this study would represent erroneously
· rejecting the null hypothesis, i.e., claiming that LFES does affect muscle strength
or endurance in MS subjects, when in fact, it does not. Since the safety and
comfort of LFES has been well established and does not include any negative side
effects, the consequences to the subjects of such a Type I error are minimal
enough to permit further investigation within the limits of reasonable cost and
time. However, care must also be taken not to instill false hopes in individuals
with MS if subsequent investigations also prove negative. For this preliminary
investigation, the conditions set forth by Franks and Huck apply allowing the
statistical results of this study to merit evaluation with a higher significance level
of .10 or .15. Statistical significance would then encompass the time and group
interaction for the dependent variables, average peak torque and average mean
force.

AFS: Unlike the approaching significance for peak torque and mean force, the
statistical result for fatigue slope on the interaction of time and group was far
from obtaining significance (p<. 83 81 ). However, being so far from statistical
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significance may divulge information just as important as coming close to
significance.
The results of muscle fatigability of this study being so divergent from
previous studies may relate to methodological differences. In the previous
research muscle contractile changes of twitch:tetanus ratio and half-relaxation
time, along with muscle fatigue, were ascertained by electrical stimulation testing
procedures. Changes in contractile properties and muscle fatigue usually occurred
simultaneously. In the present study muscle fatigue was measured by volitional
performance criteria. Research has yet to prove that changes in muscle contractile
pr�perties or fatigue detected by electrical stimulation testing have any correlation
with changes in muscle fatigue detected by volitional performance testing. This
leads to the possibility that changes in volitional muscle performance are a distinct
entity from electrically detected changes, and may occur elsewhere along the time
course of changes due to LFES. Pette 1 9 reported that enzymatic and contractile
changes in muscle happen in conjunction with each other and precede changes in
myosin light forms and histological fiber type. As discussed previously, fatigue
resistance to tetanic contraction is often considered as a corollary to muscle
contractile changes. Although this study used the 6-week stimulation protocol of
Gauthier et al. 22 which demonstrated enzymatic changes, changes in muscle
contractile properties can only be assumed since they were not tested.
Performance changes, however, may require a longer duration of stimulation to be
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expressed and may only occur concommitantly with the later changes in myosin
light forms and histological fiber type.
It is also interesting to note that the fatigue slope decreased similarly in the
experimental and the control leg. This could be the result of a cross-over effect
with the electrical stimulation. The cross-over effect, or cross-training effect,
contends that muscle changes may also occur in the opposite unstimulated limb as
a result of the stimulation of the experimental leg. This concept is debated in the
literature. Scott et al. 3 1 suggest a possible carry-over effect from the stimulation
in their subjects with muscular dystrophy; however, many studies have reported
no muscle contractile changes in the contralateral leg in response to a LFES
program. 15 • 1 7 •20 The general consensus from previous research is that, if present,
the cross-training effect is very minimal. However, these studies used the
electrical stimulation testing methods previously discussed, and based their
conclusions regarding cross-training on the data obtained in that manner. It is
quite possible that the emergence of a cross-training effect becomes more readily
apparent when volitional performance testing methods are used as in the present
study. In subjects with central nervous system lesions (as in MS), motor learning
may be a factor in the contralateral limb due to stimulation on the experimental
leg.

Conclusions Regarding the Research Question: The traditional manner of
assessing the value of statistical results is by using the pre-determined critical
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significance level as a dividing line between what is meaningful and what is not.
However, this approach may not always address all levels of the study's results
which deserve consideration. This gray area of determining significance and non
significance is described by Moore and McCabe66 as follows:
Making a decision is different in spirit from testing
significance, though the two are often mixed in
practice. Choosing a level alpha in advance makes
sense if you must make a decision, but not if you wish
only to describe the strength of your evidence.
In clinical research of the exploratory type, consideration of the statistical
results for possible trends becomes as important as the "critical" significance level
for discerning what may represent meaningful information. Areas to be considered
for future research may be indicated by trends in the data analysis. In this study,
the interaction of time and group factors for the variables average peak torque
and average mean force strongly suggest a possible meaningful interplay between
these two factors. As presented in the 'Results' section of this paper, graphs of
this interaction show the trend of increasing peak torque and increasing mean
force over the 6-week stimulation time for the experimental legs versus the
control legs. Inspection and consideration of this information provides a
foundation for future research, possibly involving a greater number of subjects or
a longer stimulation duration in the protocol.
Even if .05 is heralded as the necessary 'critical' level for discerning
significance versus non-significance, the distinction between "failing to reject" and
"accepting" a null hypothesis is still a worthy concept. Accepting a null hypothesis
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based on an alpha level of . 05 incurs a fairly high chance of making the Type II
error of accepting a false null hypothesis. 67 The cost of this decision has been
outlined above in the discussion for a more generous interpretation of the data. In
contradistinction to this, failing to reject the null hypothesis means only that the
results of a study do not substantiate completely disregarding the null hypothesis.
In this study, at the . 05 significance level, the results preclude rejecting the null
hypothesis and accepting that the LFES program makes a significant difference in
muscle strength and endurance; however, the results do not force accepting the
null hypothesis with the alternative conclusion that LFES has no effect. Instead,
the decision of failing to reject the null hypothesis recognizes that future research
may better clarify the effects of a LFES program on individuals with MS. As
cited above, this decision is permissible on a limited basis since the consequences
of a Type I error are minimal.
In the previous section, the statistical results for the dependent variables have
been inspected with possible explanations for these results presented. Information
can also be derived from an exploration of the data.

Exploration of the Data

A further objective in this study was to be alert for response trends in regards
to certain traits or characteristics. One method to search for response patterns in
the stimulated muscle is to examine changes in the experimental muscle as it
differs from the control. In order to compare one subject to another, the percent
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change for each variable for the control and experimental legs were compared to
formulate a new index of percent change for the experimental leg. This adjusted
index describes the degree of change in the experimental leg while accounting for
the change which also occurred in the control leg. As an example, for subject
number two, the APT of the control leg increased 2. 69% while that of the
experimental leg decreased 3 . 48%. Accounting for the increase in the control leg,
the real decrease in strength of the experimental would be a larger 6. 17%.
Adjusted values for each of the three dependent variables, APT, AMF, and
AFS, were examined for response patterns. Previous research has suggested that
differing responses may occur in relation to the initial strength of the muscle being
stimulated. Speculation of response differences due to the stimulation intensity
tolerated by the subject has been a concern as well. To examine strength levels
across subjects, each subject's initial MVIC was taken as a percent of that
subject's body weight and arranged by increasing strength . The corresponding
adjusted values for APT, AMF, and AFS were inspected for trends. A similar
continuum was created based on the intensity of the stimulation used by the
subject. The force values elicited by the portable stimulator at the post-treatment
testing session were expressed as a percentage of each subjects MVIC and ranked
with the corresponding adjusted values for each dependent variable.
Inspection of the data as graphed in Figure 4 does not demonstrate any
response trends for the initial strength on any of the three variables. Although the
subject to subject variation is broad along the strength continuum, examination of
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Figure 4. Change in APT, AMF, and AFS as a Function of Initial Strength
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the end ranges of initial strength shows only minimal deviation from the zero line
for APT, AMF, and AFS. The greater changes in peak torque and mean force
corresponding to a lower initial strength as seen in the second graphed point
belongs to the subject which received five days of intravenous cortisone just prior
to the study's termination and final testing. It is possible that this increase in
strength is a reflection of that treatment.
Changes in average peak torque, mean force, and fatigue slope did not exhibit
any response pattern for the stimulation intensity tolerated either. Similar to the
data of initial strength, a wide intersubject variability was displayed with minimal
differences at either extreme of the stimulation intensity continuum.
Lastly, the input from the questionnaire distributed after the study's end will
be reviewed. Despite a wide range of responses in other aspects of this study, the
sentiments expressed in the questionnaire are very similar. Seven out of nine
forms were returned. It was not known how the stimulation would be tolerated
by the subjects with MS since no previous studies had documented its use on
individuals with MS. All subjects felt the stimulation improved the muscle being
stimulated. Specific examples of improvement cited were increased strength (with
improved functional performance), decreased muscle spasms, less muscle stiffhess,
decreased edema, and decreased pain in the stimulated muscle, and sometimes the
entire leg. The major complaint of the stimulation protocol revolved around the 3
hour a day time requirement, although six out of seven still reported that they
would repeat this stimulation protocol again. No adverse side effects were
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reported as a result of the stimulation, and several subjects described the
stimulation as being pleasant. Overall, the stimulation protocol was comfortable
and well tolerated by the subjects. All subjects felt LFES had potential for
helping individuals with MS.

72

CHAPTER 6

CONCLUSIONS

The effects of a low frequency electrical stimulation protocol, as documented
in previous animal and human subject research, have been investigated in this
study in a practical application involving a clinical population. A low frequency
electrical stimulation program of 8 Hz applied to the quadriceps muscle of
individuals with MS did not produce a significant change in the maximum strength
of the muscle, as assessed by peak torque and mean force measurements. The
endurance of the muscle, as defined by a fatigue slope calculation, was far from
the expected statistical significance. This was most probably due to decreases in
the fatigability of both legs, and suggested the possibility of a cross-over effect.
Although not significant at the . 05 probability level, a trend for improvement in
the peak torque and mean force of the muscle was demonstrated, possibly
suggesting an increase in the muscle's functional strength and endurance.
The safe application of this type of LFES for both clinical and home use in
individuals with MS has been demonstrated by this study. The 6 weeks of home
use resulted in no reported problems as a result of using the portable stimulator.
Subjective responses by the participants indicated that the stimulation is not only
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comfortable, but beneficial in reducing edema, pain, and spasms in the stimulated
muscle. Functional improvements were reported as well.
The potential of a LFES to offer a viable short-term rehabilitation option to
increase the functional strength and endurance of selected muscles in individuals
with MS is suggested. Recognition is also given to the need for more research to
further assess the effects of LFES in subjects with MS, in hopes of documenting
changes in performance criteria s11;ggestive of a conversion of fast twitch muscle
to slow twitch. Research must also determine the optimum parameters for clinical
application. Details such as daily stimulation time, overall program duration, and
the stimulation frequency and intensity offering the most beneficial results should
be quantified by research.
Other research concerns prompted by this study include:
1 ) Determining if a longer program of LFES will exhibit greater changes in the
performance criteria of a muscle.
2) Investigating on a larger sample size whether changes in muscle strength or
endurance vary according to the initial strength or functional ability of the
individual . .
3 ) Determining the relationship between the muscle assessment procedures of
electrical stimulation testing and volitional muscle contraction technique.
Inherent in this is discerning if muscle contractile changes demonstrated by
electrical testing have any corollary in performance changes in the muscle.
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4) Ascertaining where changes in performance criteria fit along the continuum of
changes already demonstrated to occur in enzymatic activity, muscle contractile
characteristics, myosin light chains, and histological fiber type.
5) Investigating the role of a cross-over effect with stimulation when volitional
testing procedures are used, particularly in subjects with CNS lesions.
6) Lastly, histological fiber typing of the stimulated muscle before and after
administration of a LFES program to reveal any changes in the muscle's
morphology due to the stimulation, and to assess if results with LFES programs
vary according to the initial fiber type predominance demonstrated.
A final note relates to the clinical application of LFES program for individuals
with MS. Perhaps it is most appropriate to view a LFES as an alternative method
of providing an endurance training program with the additional benefit of being
able to selectively target individual muscles which need it most. As suggested
earlier, its greatest asset may be as a short term method of increasing a muscle's
functional strength and endurance until volitional exercises can be initiated. This
may be particularly helpful in individuals with MS by retraining specific muscles
left weak after an exacerbation of the disease.
The psychological impact to the individual must also be considered.
Subjective responses by the participants in the study emphasized the
encouragement and pleasure in seeing a weak muscle contract. Because of this,
care must be used not to apply the electrical stimulation indiscriminately to any
muscle group without first assessing the needs and goals of the area being treated.
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It is tempting for an individual to apply the stimulation to many different muscles,
since it is rewarding to see the weakened muscle contract. However, for each
muscle to which the stimulation is applied, a separate evaluation is required to
fine tune the electrical stimulation parameters. In this way, the most comfortable
LFES program is delivered in the most efficacious manner. It should also be
remembered that ascertaining many of the details of the most appropriate clinical
protocol has yet to be determined by research.
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SUBJECT HISTORY AND INFORMATION SHEET

DA'IE:________

NAME :________________

AGE:______

WEIGJIT:_____

SEX: ____

PHYSICIAN :__________________________
LAST APPOINTMENT:_________ NEXT APPOINTMENT:_______
MEDICAL HISTORY
Years since disease diagnosis:________________________
Frequency per year of exacerbations:_____ Average dmation of exacerbation:______
Onset of last exacerbation :_________________________
Lower extremity tremors or spasms?____ Frequency:____(per
. /hour)____(per/day)
History of heart disease?______ Pacemaker?_______ Pregnant?_____
General heat tolerance:___________________________
MEDICATIONS: (List medications including how long on each)

STRENGffl AND FUNCTIONAL STATUS:
Any known disability ratings?______ Kurtzke EDSS rating according to table (0-9)___
Quadriceps strength :__________(Riaht) ___________(Left)
Knee ROM:

(Ri&bt)

(Left)

Cutaneous sensory status of thip :._________(Rigbt) _________(Left)

ACTMTY LEVEL:
Currently participating in regular exercise?____________________
Jfyes, for how long?___________ Currently receiving physical therapy?____
If yes, what kind and how long?_______________________
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Disabillty Status Scale in Multiple Sclerosis
(In parentheses are listed usual equivalents for defects in the ftmctional systems.)
0 - Normal neurologic examination (all grade O in .ftmctional systems)
1 - No disabilitiy and minimal signs such as Babinski sign or vibratory decrease (grade I in ftmctional
system)
2 - Minimal disability, for example, slight weakness or mild gait, sensory, visuomotor disturbance (1 or 2 fimctional
systems, grade 2)
3 - Moderate disability though fully ambulatory (for example, monoparesis, moderate ataxia, or combinations of
lesser dysfim.ctions) (1 or 2 fimctional systems, grade 3, or several, grade 2)
4 - Relatively severe disability though fully ambulatory and able to be self-sufficient and up and about for some
twelve hours a day ( 1 ftmctional system, grade 4, or several, grade 3 or less)
5 - Disability severe enough to preclude ability to work a full day without special provisions. Maximal motor
ftmction: walking maided no more than several blocks (1 fimctional system, grade 5 alone, or combination of lesser
grades)
6 - Assistance (canes, crutches, or braces) required for walking (combinations with more than 1 system, grade 3 or
worse)
7 - Restricted to wheelchair but able to wheel self and enter and leave chair alone (combinations with more than 1
system, grade 4 or worse; very rarely pyramidal , grade 5 alone)
8 - Restricted to bed but with effective use of arms (combinations usually grade 4 or above in several fimctional
systems)
9 - Totally helpless bed patients (combinations usually grade 4 or above in most fimctional systems)
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April 10, 1994

--------

Knoxville Neurology Clinic
3 50 UT Professional Office Building
Knoxville, Tennessee 3 7920

Dear Dr.

-----

I am a licensed physical therapist currently pursuing a Ph.D. in Exercise Science at the
University of Tennessee. As part of that degree, I hope to conduct a research project on
the effects of a low frequency electrical stimulation program on the quadriceps muscle of
individuals with multiple sclerosis.
The research protocol has been approved by the Human Subjects Review Committee at
the University. I have also obtained approval from the National Multiple Sclerosis Society
- Setenga Chapter - to recruit subject volunteers from area multiple sclerosis support
groups. In so doing, one of you patients,______ has expressed an interest in
participating in the study. Acceptance into the study is contingent upon physician
approval. I have enclosed a brief summary of the research protocol as well as an approval
form for ______. Also enclosed is a self-addressed stamped envelope for
returning the form, should you approve.
Thank - you for your time in considering your patient for study participation. I hope to
begin data collection as soon as possil>le. For those individuals participating in the study,
a follow-up letter upon study completion will be provided.

Sincerely,

Lisa L. Oglesby
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Patient Name:

-----

Date: April 19, 1994

The above individual has my permission to participate in the research protocol involving a
low frequency electrical stimulation program to the quadriceps muscle of individuals with
multiple sclerosis.
Comments or special considerations for the above patient: ___________

Has this individual been assessed by any disability scale rating? If so, would you please
state the scale and the rating and the date given?______________

Physician's Name: _______ MD
Date: ---------

Signature:___________
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CONSENT FORM
Title of Research Project: The Effects of a Low Frequency Electrical Stimulation
Program on the Strength and Endurance of the Quadriceps Muscle in Individuals with
Multiple Sclerosis
Investigator:

Lisa L. Oglesby, PT
Department of Human Performance and Sport Studies
University of Tennessee, Knoxville
974-5 111 (UT); 549-8668 (pager)

Description of Project:
The pwpose of this investigation is to see if a low frequency electrical stimulation
program causes any changes in strength or endurance in the thigh muscle of individuals
with multiple sclerosis. It should be noted that this study is a research project to evaluate
the effects of an electrical stimulation program and should not be considered as a physical
therapy treatment program
Procedures:
After your physician's approva� the study will last approximately eight weeks. The
first and last weeks will be used for testing the strength and endurance of both of your
thigh muscles, at least two times each week, in the clinic. This will be done by your
attempting to straighten your knee and hold it for five seconds against a machine that will
indicate the strength and endurance of the muscle.
During the middle six weeks of the study, you will use a portable electrical stimulation
device in the convenience of your home. The electrical stimulation leve� and how long it
is to be worn will be gradually increased up to two sessions a day, for one and one-half
hours each session. This is to be done six days a week for six weeks. The duration of the
stimulation will be increased fifteen minutes each day during the first week until the one
and one-half hour maximum is reached. The intensity of stimulation will be ultimately
determined by you based on your comfort level Generally, as you adjust to the feeling of
the stimulation, greater intensity levels are possible. The device does not prevent your
participation in most other simple activities, for example, walking around the house. I will
visit your home weekly, or as needed, to provide assistance.
Potential Risks and Benefits:
Possible risks may include temporary discomfort due to the electrical stimulation
sensation. You may also experience skin irritation under the electrode pad. Transient
muscle soreness or muscle fatigue could also occur, but I have not seen this reported in
the past.
Possible benefits could be a small increase in strength or endurance of the muscle being
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Consent Form - cont'd

stimulated. However, past studies have shown any changes to be temporary and to last
only as long as the stimulation continues.
· A few studies involving healthy subjects with normal muscle strength have shown a
slight decrease in maximal strength in conjunction with the increase in muscle endurance,
ahhough this is not considered an abnormal response. Most studies involving muscles that
are weak initially showed either no change or an increse in strength.
The portable stimulation machine is safe for home use provided the following
precaurions are followed. The equipment should not be worn while operating any
machinery such as power tools or driving a car. The unit should be used only on the area
of the body, as instructed, by the investigator. The unit should be kept away from
children.
Qualifications of Investigator: The investigator, Lisa Oglesby, is a licensed physical
therapist familiar with the strength testing equipment and the stimulation device, and has
worked with multiple sclerosis individuals in the past.
Authorization:
I have read the above information and understand my role in this project as well as the
risks involved. I have had the procedure explained and demonstrated to me. In addition, I
am aware that:
I . My name and my results will remain confidential. Any reference to my
participation in the study will be by an assigned subject number. Only the principal
investigator will know the number assigned to me;
2. I am entitled to have any further inquiries answered regarding the procedure;
3. Participation in the study is voluntary; refusal to participate will involve no penalty,
and I may with draw or discontinue my participation at any time.
4. In the event that physical injury occurs as a result of the study, the University of
Tennessee does not automatically provide reimbursement for medical care, or other
compensation. If physical injury is suffered in the course of research, or for more
information, please notify the principal investigator, Lisa Oglesby at 549-868 (pager).
My signature also indicates that I have received a copy of this consent form.

-----------Witness------------- Date-----------Signature____________
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Date

TESTING DATA SHEET

NAME: ____________
Checklist of Cybex Settings:

SUBJECT NUMBER: ____
Session One
Date:

Tlmefl'emp: ___

Session Two
Date:

Tlme/l'emp: ___

Calibration Date:
Rt leg

Foiward/backward lever arm setting:
Up/down lever arm setting:
Ankle resistance lever arm setting:
(Lower border superior to lateral malleolus)
Foot pom1ds scale:
CCW/CW setting: (Set CW for left leg)
Damping: (2)

TESTING:
Subject Positioning:
Back Cushion:
Hip Strap/Knee Strap:
Ankle Pad Secure:
Foot against backstop and locked:

Data:
Practice (three light trials):
Needle on zero line?

1st MVIC with five second bold:
R�zero; Foot back and relax:

2nd MVIC with five second bold:
R�zero; Foot back and relax:

3rd MVIC with five second hold:
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Lt leg

Rt leg

Lt leg

Motor Point Chart for Lower Extremity

Vastus Lateralis
Vastus Medialis

Adapted from: Shnoer WJ. A Manual ofElectrotherapy 4th ed. 1975, p152.
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STIMULATION PROGRESSION SHEET AND TIME LOG
Instructions: I. Please record the clock time of the session in the boxes below. Example: 2:00 - 2: 1 5 pm
2. Note the schedule of increasing stimulation time dming the first week up to 90 minutes.
After this is reached, continue with 1 hour and 30 minutes, each session, for the rest of
the program. Remember, you have one day off each week.
3. After the first week, increase the intensity of the stimulation ( by twning up the dial ),
within what is comfortable for you, to maintain a good contraction in the muscle.
4. Record the dial setting in the comments box, along with any other comment
Additional space for comments is provided below each week's stimulation box.
Week One:

Day

Date

First Session
(15 min)
(3 0 min)
(45 min)
(60 min)
(75 min)
(90 min)
(90 min)

Second Sesssion
(15 min)
(30 min)
(45 min)
(60 min)
(75 min)
(90 min)
(90 min)

Dial Setting/Comments

Comm ents :_________________________________

Week Two:
Dav

Date

First Session
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)

Second Session
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)

Dial Setting /Comments

C...-a:_________________________________
Week Three·
Dav

Dial Settinw'Comments
Second Session
First Session
(
90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
min)
(90
min)
(90
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
Comments:. _________________________________
Date
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STIMULATION TIME LOG - Continued
Week Four :
Day

Date

Week Five:
Day

Date

Week Six:
Day

Date

Dial Setting/Comments
Second Session
First Session
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
_____
Com m ents :___________________________

Dial Setting/Co mm ents
Second Session
First Session
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
min)
(90
in
(90 m )
o
ents
C mm
:________________________________

Dial Setting/Comments
Second Session
First Session
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
(90 min)
min)
(90
(90 min)
min)
(90
(90 min)
min)
(90
(90 min)
(90 min)
(90 min)
________
Comments :________________________

Please call me on my pager if you have any questions.
To reach me by pager, dial 549-8668. After the recorded message, dial your phone num ber followed
by the # sign on the phone pad, then hang up. I will call you back as soon as I can get to a phone.
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Follow-u p Questionnaire for Electrical Stimulation Program
Name :_______(O ptional)
1. Do you feel the electrical stimulation program made a difference, for better or worse,
in the muscle, or leg being stimulated?
If so, please give any sp ecific examples you can think of__________

------------------

2. Have you been able to notice any difference in the leg since you stopped the electrical
stimulation?

-------------------------------

3. What did you dislike most about the electrical stimulation program? ______

4. What did you like most about the electrical stimulation program? ________

5. Do you think you would be likely to do this type of electrical stimulation program (3
hours a day, six days a week, for six weeks) again to either the same part of the body or to
a different part of the body? _____________________

6. Do you think you would be more likely to participate in such a program if it were for a
shorter period of time each day, say for two hours instead of three? ________
7. Do you think you would be likely to use it if it neede to be done for twelve weeks
instead of six?

--------------------------

8. If you could do exercises to provide an effect similar to the electrical stimulation, do
you think that you would be more likely to exercises six days a week, or the electrical
stimulation? Why?_________________________
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Questionnaire continued

9. Do you see this type of electrical stimulation program being helpful to individuals with
multiple sclerosis? Any particular reason why you feel this way? _________
10. Any oter comments or ideas? ___________________

Thanks for taking the time to participate in the study and to fill out the questionnaire. I
really appreciate your help !
Lisa Oglesby
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ANOVA Summary Tables for Experimental vs Control
Prior to Electrical Stimulation
For Average Peak Torgue:

Source of variation
Subjects
group
Error

DF
8
1
8

Sum of Squares
23401.353
144. 897
4803.662

For Average Mean Force:

Source of Variation
Subjects
group
Error

DF
8
1
8

Sum of Squares
1 8374. 582
52.839
4093.036

For Average Fa!!gue Sloee:

Source of Variation
Subjects
group
Error

DF
8
1
8

Sum of Squares
329.355
2.683
37. 897

Mean Square
2925. 1 65
144.897
600.45 8

F

p

.241

.6365

Mean Squares
2296. 823
52.839
51 1.630

F

p

. 103

.7562

Mean Squares
41. 169
2.683
4.737

F

p

.566

.4732
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Epsilon Correction
1.00

Epsilon Correction
1.00

Epsilon Correction
1 .00

RAW DATA

Pre-treatment
Experimental
APT

Post-treatment

Control

Experimental

Control

29.94
23.35
10.74

65.54
53.03
7.60

23.64
21.06
5.21

59.22
47.91
7.49

#2

APT 110.74
AMF 97.84
6.07
AFS

92.66
85.20
5.17

106.89
97.66
4.41

95.15
88.34
4.84

#3

APT
AMF
AFS

61.47
55.19

4.88

48.56
42.99
6.87

71.19
65.68
3.44

54.69
52.06
2.63

#4

APT
AMF
AFS

20.65
20.23
2.27

35.39
30.84
5.99

32.68
32.31
1.22

35.49
35.15
1.60

#5

APT
AMF
AFS

89.73
88.14
1.5

52.88
44.78
7.76

98.65
95.60
2.67

47.23
39.30
1 1.03

APT
AMF
AFS

89.27
77.94
13.80

165.88
144.25
10.89

127.46
11 1.87
7.96

179.44
· 155.80
8.83

APT
AMF
AFS

16.95
16.53
1.4

32.77
32.50

22.33
21.97
1.02

45.66
45.33
.50

APT
AMF

AFS

10.08
6.63
14.69

7.01
4.37

15.86

14.51
10.88
11.19

9.53
7.00
10.18

APT
AMF
AFS

52.89
51.05
3.1 1

32.10
29.78
4.79

81.8 1
77.71
4.03

44.07
41.90
3.01

#1 :

#7

#8

#9

AMF
AFS

.48
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ANOVA Summary Tables
for Treatment Effects

For Average Peak Torque:

...source. of Variation. ......DF........sum of Squares........Mean _Squares ....... F ................P ................Epsilon Correction..... .
6437.958
5 1 503.662
8
Subjects
1
507.225
507.225
4.958 .0566
time
Error
8
81 8.354
102.294
1.00
group
1
49.914
49.914
.044 .8390
Error
8
9069.846
1 133.73 1
1.00
1
99. 168
99. 168
3.288
. 1 073
tXg
8
241.252
30. 156
1 .00
Error

For Average Fa!igue Slo,ee:

-· Source _of Variation ....... OF ....... Sum. of_Squares ....... Mean _Square ........F................ P................ Epsi lon _Correction .... .
58. 1 10
464.880
8
Subjects
1
29.539
29.539
6.442 .0348
ti me
Error
8
36. 684
4.585
1.00
7.03 1
1 . 064 .3325
1
7.03 1
group
Error
8
52. 870
6.609
1 .00
. 1 12
.045 . 83 8 1
1
. 1 12
txg
Error
8
20. 148
2. 5 1 9
1.00
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ANOVA Summary Table and Simple Effects
for Average Mean Force

ANOVA Table:

...Source. of Variation .......DF ........Sum of Squares........Mean Square ....... F.................P................ Epsilon. Correction .... .
8
40195.096
5024.387
Subjects
1
567. 154
567. 154
7.55 1
.025 1
time
Error
8
600.91 1
75. 1 1 4
1. 00
1
2. 195
2. 195
.002 .9635
group
8
786 1.08 1
982.635
Error
1.00
1
77.41 1
77.4 1 1
3.495 .0985
tXg
Error
8
1 77. 1 84
22. 148
1 . 00

Simple Effects for time x group interaction:

...Effect .................MSn .............. DFn ....... DFe ....... MSe .............. F ................P...........
t at exp
t at control
g at pre
g at �

53 1 . 8 1 5
1 12. 750
52. 839
26. 767

1
1
1
I

8
8
8
8

72.683
24. 579
5 1 1 .630
493. 1 54

7.3 1 7
4.587
. 1 03
. 054
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.027
.065
.756
. 822
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Exercise Science at the University of Tennessee to further her professional career.

101

